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ABSTRACT 
 
Patterns of Antimicrobial Resistance among Enteric Bacteria Found in Multi-Site Group-
Level Cohorts of Humans and Swine.  (December 2004) 
Linda Diane Campbell, B.S., Arizona State University 
 
Chair of Advisory Committee: Dr. H. Morgan Scott 
The prevalence of antimicrobial resistance (AMR) phenotypes and genotypic 
characteristics (Class 1 integron and AMR gene cassettes) in commensal Escherichia coli 
(EC) and vancomycin resistant Enterococcus faecium (EF) isolated from humans and 
swine in a semi-closed, integrated farrow-to-fork population were evaluated in a cross-
sectional study.  Our objective was to establish baseline antimicrobial resistance patterns 
and to evaluate the stability of isolate recovery phenotype within multiple grab samples per 
collection day and over multiple biweekly samples collected during a period of several 
months.  This data will serve as a baseline for continuing longitudinal studies within the 
population.  These continuing studies should produce the first comprehensive 
epidemiological data to document the transmission dynamics of antimicrobial resistance in 
the farrow-to-fork continuum.  Outcome variables assessed included: phenotypic resistance 
in EC, pan-susceptibility, multi-resistance and genotypic resistance. Potential predictor 
variables included: 1) host species, 2) unit, 3) unit type, 4) housing cohort by species, and 
5) time of day.  There were significant differences (p<0.05) between host species with 
swine at higher odds for both single and multiple resistance.  There were also differences 
in resistance based on unit location, unit-type, and housing cohort within both humans and 
 iv
swine.  Our study found no significant differences (p>0.05) in resistance between swine 
workers and non-swine workers with the sole exception of resistance to cephalothin, with 
non-swine workers at 1.89 higher odds for resistance (p=0.02).  A total of 17 VRE were 
isolated from human wastewater samples, and to the author’s knowledge these represent 
the first environmentally isolated VRE in the U.S.  Several unique multi-resistance 
phenotypes were observed and future evaluation of AMR phenotype in continuing 
longitudinal studies provides a unique opportunity to study phenotypic patterns and 
dissemination through the study population.  
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INTRODUCTION 
 
The accidental discovery of penicillin in 1928 proved to be one of the greatest 
therapeutic advances of the century.  Many believed that this discovery signaled the 
beginning of the end of infectious diseases caused by bacteria; instead, more than 70 
years later antimicrobial resistance (AMR) in pathogenic bacteria is considered one of 
the greatest global threats to public health. Almost as rapidly as antimicrobials have been 
developed, marketed and prescribed, resistant bacteria have emerged.  Widespread use 
of antimicrobials in the 1940’s, while effective in treating many infectious diseases, was 
mirrored by the development and spread of AMR among bacteria.  By the end of the 
1960’s transferable AMR had been detected and characterized (Witte, 2000).  The use of 
antimicrobials provides selective pressure for, and in turn propagates resistant bacteria.  
In the presence of an antimicrobial, the resistant bacterium has a selective advantage and 
its numbers are amplified, while susceptible bacteria are inhibited or killed (Collier et 
al., 1998).  Antimicrobial-resistant bacteria are now recognized to be both 
geographically widespread (worldwide) and of great public health importance.  AMR 
leads to increasing difficulty in treating infections in human patients and propagates 
transmission of resistant bacteria within the hospital setting.  Resistant bacteria in food-
producing animals has lead to much debate and speculation about the role of 
transmission from animals to humans (van den Bogaard et al., 2001).  Resistance to two  
 
___________ 
This thesis follows the format and style of Foodborne Pathogens and Disease. 
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or more classes of antimicrobials in microbial pathogens like Escherichia coli is now 
commonplace in isolates from both veterinary and human medicine (Bass et al., 1999). 
While no one argues the widespread geography and importance of AMR, the 
debate over whether animal agriculture is to blame for increased resistance in humans 
has raged for over 30 years (Snary et al., 2004).  The first large-scale commissioned 
report to assess the role of food-producing animals in AMR transmission was published 
in 1969.  The Swann report – based on the United Kingdom experience – was the first to 
link an outbreak of salmonellosis in humans to consumption of beef in which 
antimicrobials had been used (Swann, 1969).  
With the advent of molecular techniques in the 1980’s and 1990’s a variety of 
‘fingerprinting’ methods have been employed such as pulse field gel electrophoresis 
(PFGE), ribotyping, and various methods of polymerase chain reaction (PCR) to try to 
link resistant strains of bacteria isolated from human clinical specimens to animal 
agricultural sources. By identifying unique characteristics within the DNA, these 
methods attempt to relate the patterns observed both within and between species to 
establish potential relationships and/or similar characteristics.  PFGE is particularly 
useful for bacterial sub-typing and is often considered the gold standard of molecular 
typing methods (Werner et al., 2003; van den Braak et al., 2000).    
Many researchers (reviewed by Shea, 2003) and policy makers (Tollefson and 
Flynn, 2002) believe that the association between resistance traits found in animals and 
those found in humans provides sufficient evidence to implicate the use of 
antimicrobials in agriculture as a cause of resistance in humans and to justify policy 
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changes (e.g. discontinued use of growth promoters in animals) in antimicrobial 
regulation and use (Phillips et al., 2004).  The United States Food and Drug 
Administration (U.S. FDA) is the government agency charged with the responsibility of 
evaluating all medicines allowed for human and veterinary use and its mission is to 
promote and protect public health.  The U.S. FDA initially investigated the role of AMR 
in the United States as early as 1977, but was widely criticized for recommending 
actions to withdraw penicillin and tetracyclines from animal feed without adequate 
epidemiological evidence (Tollefson and Flynn, 2002).  This struggle between the 
demand for more epidemiological evidence of transmission of AMR from animals to 
humans before taking action and the immediate need to protect human health in the 
absence of unequivocal ‘proof’ (i.e., the ‘precautionary principle’) has remained at the 
heart of the heated debate for over three decades. 
Proponents of a scientific risk assessment framework argue that agencies such as 
the U.S. FDA and U.S. Centers for Disease Control and Prevention (CDC) have not 
adhered to the definition of hazard identification, which is the first step in quantitative 
risk assessment.  At the U.S. FDA meeting on Draft Guidance held in 2002, Dr. Gregg 
Clayclamp, Director of U.S. FDA’s Center for Veterinary Medicine (CVM) Scientific 
Support & Generic Animal Drug Staff, described hazard identification as “the process of 
determining whether exposure to an agent can cause an increase in the incidence of a 
health condition (U.S. FDA, 2002).”  “Hazard identification is then a statement of 
possibility rather than probability” (Dean and Scott, 2004).  Merely identifying AMR as 
a “hazard” is not sufficient for scientists who feel that the actual characterization of that 
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risk has not been amply demonstrated.  Dr. Lyle Vogel of the American Veterinary 
Medical Association states, “[we] believe that the agency (U.S. FDA) has demonstrated 
that a hazard exists, however, the agency has not adequately characterized the risk to 
humans” (U.S. FDA, 1999).  
Even within government organizations such as the U.S. Department of Health 
and Human Services (DHHS), which includes the U.S. FDA and CDC, and the U.S. 
Department of Agriculture (USDA), there has been disagreement over the appropriate 
regulatory responses to AMR.  According to the 1999 report entitled, Food Safety: The 
Agricultural Use of Antibiotics and Its Implications for Human Health, the USDA is not 
convinced enough knowledge is available to make substantive regulatory changes, and 
that further research is warranted, whereas the DHHS feels there is sufficient evidence to 
justify regulation (GAO, 1999). 
In order to address both the disagreement between governmental agencies and 
the need for quantitative data regarding AMR, the U.S. FDA, CDC, and USDA 
established the National Antimicrobial Resistance Monitoring System for enteric 
bacteria (NARMS) in 1996.  The role of NARMS is to prospectively monitor changes in 
antimicrobial susceptibilities of zoonotic enteric pathogens from human and animal 
clinical specimens, carcasses of food-producing animals at slaughter, and from retail 
food (Tollefson and Flynn, 2002).  Typically, NARMS surveillance data are derived 
from human clinical enteric pathogen isolates whereas the animal isolates include both 
clinical and non-clinical sources, therefore, any comparisons and inferences remain 
difficult. 
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Although the NARMS collaboration has been a step forward in AMR research, 
there is still wide disagreement even among the NARMS collaborators.  NARMS 
collaborators charged with protecting public health generally believe that adequate 
research exists to warrant regulatory changes, while those charged with protecting 
animal health generally argue that further research is warranted.  Whereas the NARMS 
program is an important first step, there is still a need for expansion of research activities 
to include improved sampling along the entire farm-to-fork continuum (Isaacson and 
Torrence, 2002). 
Objectives 
To address this need, the research described hereafter was designed to provide 
initial phenotypic and genotypic characterization of the potential transmission dynamics 
of AMR in a uniquely integrated population of animals and humans with minimal 
outside influence occuring due to in- and out-migration and disparate food sourcing.  
The major objective of this study was to establish baseline antimicrobial resistance 
patterns of enteric bacteria from animals and humans within the study population; 
specifically, phenotypic and genotypic traits which are both unique and common to 
commensal Escherichia coli (EC) and Enterococcus faecium (EF) derived from the 
different sources.  A secondary objective was to evaluate the stability of bacterial isolate 
phenotype within multiple grab samples per collection day and over multiple biweekly 
samples collected during a period of several months.  We propose that continuing 
longitudinal studies in this population should produce the first comprehensive 
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epidemiological data that will document the transmission dynamics of antimicrobial 
resistance in the farrow-to-fork continuum. 
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LITERATURE REVIEW 
Overview of Antimicrobial Resistance 
An antimicrobial is defined as a drug, chemical or substance which kills or 
inhibits the growth of a microbe (CDC, 2004). There are several classes of 
antimicrobials which are used to treat infectious diseases caused by bacteria.  These 
include the following: aminoglycosides, β-lactams, glycopeptides, fluoroquinolones, 
macrolides, streptogramins, sulphonamides, and tetracyclines.  Amingolycosides target 
the 30S subunit of the bacterial ribosome and interferes with protein synthesis.  β-
lactams target enzymes required by the bacteria for synthesis of peptidoglycan and 
interfere with synthesis of the cell wall.  Glycopeptides interfere with the synthesis of the 
bacterial cell wall by targeting the D-alanyl-D-alanine terminal dipeptide and preventing 
the reaction used to link peptidoglycan precursors.  Fluoroquinolones inhibit synthesis of 
DNA gyrase, which is responsible for negative supercoiling of double-stranded DNA 
which balances the positive supercoiling of DNA replication. Without negative 
supercoiling irreparable breakages occur in the DNA strand. Macrolides target the 50S 
subunit of the bacterial ribosome and block the exit of the peptide chain.  Streptogramins 
are related to macrolides and also target the 50S subunit and inhibit protein synthesis.  
Sulphonamides target the para-aminobenzoic acid molecule which is used to synthesize 
folic acid by the bacteria and blocks the synthesis of folic acid.  Tetracyclines target the 
30S subunit of the bacterial ribosome and inhibit protein synthesis by preventing transfer 
of amino acids to the ribosome. Some of the more commonly used antimicrobials within 
the aminoglycocide class include: kanamycin, streptomycin, gentamicin, spectinomycin, 
 8
neomycin, and amikacin (Davies and Wright, 1997).  Macrolides include tylosin, 
erythromycin, clarithromycin, and azithromycin (Martel et al., 2002).  Lincosamides 
include lincomycin and clindamycin (Martel et al., 2002).  β-lactams encompass the 
penicillins and cephalosporins such as ceftiofur and cephtriaxone.  The sulphonamide 
class contains sulphamethoxazole and potentiated sulphonamides such as trimethoprim 
(of the diaminopyrimidine drug class) and sulphamethoxazole.  Streptogramins include 
quinupristin/dalfopristin (Synercid®) and virginiamycin (Klare et al., 2003). Drugs 
within the tetracycline class include chlortetracycline, oxytetracycline, tetracycline, 
limecycline, and doxycycline (Chopra and Roberts, 2001).  Fluoroquinolones include 
ciprofloxacin, ofloxacin, norfloxacin, lomefloxacin, levofloxacin, enoxacin, and 
sparfloxacin (Bakken, 2004). 
Antimicrobials are intensively used in human medicine, veterinary medicine and 
animal agriculture (Bailar III and Travers, 2002; Catry et al., 2003).  Antimicrobial 
usage is considered the most important factor promoting the emergence, selection, and 
dissemination of resistant organisms in both veterinary and human medicine (van den 
Bogaard et al., 2001).  As a result of widespread use of antimicrobials and subsequent 
dissemination of resistant bacteria, AMR has been documented worldwide in both 
human and veterinary settings. 
In order to further investigate the complex subject matter of AMR and risks for 
transmission, relevant subject matter will be presented concerning: 1) the role and use of 
antimicrobials in human medicine and animal agriculture, 2) the acquisition of resistance 
within bacteria, 3) the role of resistant commensal EC and EF, 4) phenotypic expression 
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of resistance, 5) genotypic traits in resistance, and 6) integron-mediated resistance.  The 
body of evidence concerning the risk of transmission of resistant bacteria from animals 
to humans will be critically reviewed.  
Use of Antimicrobials in Human Medicine 
Antimicrobial usage in human healthcare has been widespread since the 
discovery of antimicrobial agents in the 1940’s.  Approximately 22.5 kilograms of 
antimicrobials are produced in the United States each year with human use accounting 
for half of the yearly consumption by mass (Levy, 1998).  An estimated 80-90% of 
antimicrobials used in human healthcare are given in the outpatient setting (Cizman, 
2003).  While only 10% of all antimicrobials are used in the hospital setting, 
approximately 2 million individuals admitted to acute care hospitals in the United States 
are subsequently diagnosed with nosocomial (hospital-acquired) infections that are 
increasingly resistant to antimicrobial agents (Diekema et al., 2004).  
Increasing resistance to antimicrobials is of growing concern, especially with 
recent multi-resistant strains which can be difficult to treat (Shea, 2003).  Multi-resistant 
Staphylococcus auereus and vancomycin-resistant EF are increasingly a problem in the 
hospital setting, often leading to therapy failure and increased morbidity and mortality 
(Catry et al., 2003).  The economic impact of treating resistant infections was estimated 
by the Institute of Medicine (1998) to be $4 to $5 billion annually.  
Historically, physicians that practice in clinical settings have focused on the 
health of the individual rather than the population at large.  This focus has perhaps led to 
over-use and misuse of antimicrobials.  An estimated 20 to 50% of all antimicrobial 
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usage may be questionable (Cizman, 2003).  Due to concerns regarding the judicious use 
of antimicrobials in the healthcare setting, the CDC unveiled a campaign targeted at the 
reduction of AMR (CDC, 2002). 
Many of the antimicrobials used in human medicine belong to the same class as 
those commonly used in animal agriculture.  Worldwide, the β-lactams are among the 
most widespread antimicrobials used, but fluoroquinolones, sulphonamides, macrolides, 
tetracyclines, aminoglycosides, and glycopeptides are also widely administered (Phillips 
et al., 2004).  The use of similar antimicrobials in human medicine and animal 
agriculture has led to widespread concern over the potential transmission of resistant 
bacteria from animals to humans. 
Use of Antimicrobials in Animal Agriculture 
Antimicrobials are used in animal agriculture to prevent and treat illness as well 
as to promote growth.  In many food production systems it is often more efficient to treat 
the entire group of animals via feed or water rather than each animal individually.  As a 
result, large quantities of antimicrobials may be administered; however, direct data on 
the exact amount of antimicrobials used in specific animal production settings are often 
not available to the public.  This has resulted in difficulties in determining both the types 
and amounts of antimicrobials used in food animal production.  According to the World 
Health Organization (WHO), the total amount of antimicrobials used in food animals is 
not precisely known, although it is estimated that about half the total mass of the 
antimicrobials produced globally are used in farming, particularly in pig and poultry 
production (Stohr, 2000).  Estimates of antimicrobial usage in the United States in food 
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animals for both therapeutic and non-therapeutic uses range from 8.2 million to 13.2 
million kilograms per year (Isaacson and Torrence, 2002).  Approximately 90% of the 
aforementioned amount is used in animal agriculture for growth promotion and 
prophylaxis rather than to treat infection (Khachatourians, 1998). 
Several classes of antimicrobials used in animal agriculture are closely related to 
those used in human medicine: β−lactams (penicillins and cephalosporins), 
sulphonamides both with/without trimethoprim, tetracyclines, macrolides, lincosamides, 
streptogramins, and quinolones (Phillips et al., 2004).  Most antimicrobials in swine 
production are used in feed at relatively low concentrations for growth promotion or 
disease prophylaxis (McEwen and Fedorka-Cray, 2002).  Most swine are treated after 
weaning when they are most vulnerable to infectious disease (McEwen and Fedorka-
Cray, 2002).  A minimum of 17 classes of antimicrobial agents are approved for growth 
promotion and feed efficiency in the United States (Anderson et al., 2003).  Of these, the 
most commonly used in swine production are tetracyclines, macrolides (tylosin), and 
sulfa compounds such as sulphamethazine (McEwen and Fedorka-Cray, 2002). The 
previously mentioned classes of antimicrobials present a concern for potential 
transmission risk of resistant bacteria from food animals to humans.  
Acquisition of AMR in Bacteria 
There are two forms of AMR in bacteria: intrinsic and acquired. Intrinsic or 
natural resistance is widespread in bacteria and results from evolutionary adaptations of 
bacteria to the environment.  The inability of the antimicrobial to penetrate a bacterial 
cell and the lack of a target for the antimicrobial agent to act against are all natural 
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bacterial adaptations which result in AMR.  Acquired resistance may be the result of 
either a single or multiple step mutation, or may result from the lateral transfer of 
resistance traits between bacteria of the same species, of a different species, or acquired 
from the environment by a process known as transformation (McManus, 1997).  
Acquired resistance in bacteria is usually the result of acquisition of mobile 
extrachromosomal DNA elements such as plasmids, transposons and integrons rather 
than mutation (Heinemann, 1999).   
A plasmid is a circular body of double stranded DNA which is separate from the 
chromosome and carries genes that encode various traits such as virulence and AMR 
(Kaye et al., 2000).  There are two types of plasmids: conjugative and non-conjugative.  
Conjugative plasmids transfer resistance via their sex pilli whereas non-conjugative 
plasmids must have direct contact for transfer to occur.  In non-conjugative transfer, both 
the donor bacteria and the recipient bacteria have a copy of the transferred plasmid.  
Conjugative transfer is an important mechanism in AMR because transfer can occur in a 
wide range of bacterial species and can be spread to unrelated organisms.  Moreover, a 
single plasmid can contain multiple genes conferring resistance to multiple classes of 
antimicrobials (Akkina and Johnson, 1999).  
Bacteria can also acquire DNA via transduction and transformation. 
Transduction occurs when DNA is transferred via bacteriophages, which are viruses that 
attack bacteria.  Bacteriophages are very tightly packaged and do not have much room to 
carry extra DNA.  They also have a very narrow host range, and as a result transduction 
is a less important mechanism for resistance gene transfer (Akkina and Johnson, 1999).  
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Transformation occurs when bacteria pick up free DNA from the environment.  While 
the presence of DNA is common after cell lysis, the compatibility between the free DNA 
and the intact recipient is narrow (McManus, 1997). Additionally, free DNA in the 
environment would be highly susceptible to digestion by nuclease. As a result, 
transduction and transformation are not thought to contribute significantly to the 
dissemination of AMR (McManus, 1997).  
A transposon is a genetic element that contains an insertion sequence at each end.  
The insertion sequences allow the gene to jump to different locations on the 
chromosomal DNA, from plasmid to plasmid or from chromosome to plasmid 
(McManus, 1997).  Movement of a transposon is known as transposition and represents 
an important facet of AMR transfer because resistance genes can be moved from a non-
conjugative plasmid or chromosome to a conjugative plasmid, and hence easily 
transferred to other bacteria (Akkina and Johnson, 1999).  
Integrons are genetic units that include the determinants of the components of a 
site-specific recombination system capable of capturing and mobilizing genes that are 
contained in mobile elements called gene cassettes (Hall and Collis, 1995).  The 
essential components of an integron are an Int gene which encodes a site-specific 
recombinase belonging to the integrase family, an adjacent site attl, which is recognized 
by the integrase and is the receptor site for gene cassettes, and a promoter suitably 
oriented for the expression of the cassette-encoded genes (Hall and Collis, 1995).  The 
integron is composed of a 5’ conserved sequence (CS) (the integrase gene) and a 3’ CS, 
which can vary for the four different classes of integrons; classes 1 through 4 (Roe et al., 
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2003a).  The majority of integrons described to date are Class 1 integrons and the 
majority of those are associated with su1I, a gene commonly found within the 3’ 
conserved sequence (Figure 1)  (Fluit and Schmitz, 1999; Naas et al., 2001).  AMR gene 
cassettes are not always present in integrons, and the integrase gene (Int) can excise gene 
cassettes as covalently closed supercoiled circular molecules.  Integron gene cassettes 
can be deleted, rearranged and duplicated within the integron (Fluit and Schmitz, 1999).   
Integron mediated AMR is a major mechanism for transfer of resistance traits 
within both Gram-negative and Gram-positive bacteria (Leverstein-van Hall et al., 2002; 
O’Brien, 2002; Roe et al., 2003b; Mathai et al., 2004).  Integrons have been found to 
harbor the majority of resistance genes within the mobile resistance elements 
(transposons and plasmids), which allow for transfer of resistance and multi-resistance 
between bacteria (Levesque et al., 1995; Hall and Collis, 1998; Leverstein-van Hall, 
2002; Roe et al., 2003a).  Within the integron, more than 60 gene cassettes have been 
found that confer antimicrobial resistance to a variety of agents (White et al., 2001).  Of 
these, the most prevalent genes are those coding for aminoglycoside and trimethoprim 
resistance (Fluit and Schmitz, 1999; White et al., 2001).  Integrons also represent an 
important mechanism for transfer of resistance characteristics from commensal to 
pathogenic organisms and have been found to harbor multiple resistance genes at one 
time (Goldstein et al., 2001; Maguire et al., 2001; Zhao et al., 2001). 
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Figure 1. Schematic of a Class 1 integron*.  
 
*Figure adapted from Fluit and Schmitz, 1999. 5’ conserved sequence includes the int and attI regions of the 
Class I integron 
int stands for the integrase gene, which excises gene cassettes as covalently closed supercoiled molecules and is 
believed to control gene integration as well 
attI = adjacent recombination site   
P1 and P2 are promoters which are responsible for expression of the integron 
Gene cassette indicates the position of placement for the strongest level of resistance within the integron. Gene 
cassettes are not always part of an integron.  
3’ conserved sequence includes the deltaqacE, sulI and orf5  
deltaqacE is a gene cassette which carries a promoter region  
sulI is described in the text 
The Role of Commensal Escherichia coli in AMR 
Commensal bacteria, such as Escherichia coli (EC) and Enterococcus faecium 
(EF), which are naturally occurring host enteric flora, constitute an enormous potential 
reservoir of resistance genes for pathogenic bacteria (Bartoli et al., 2004; Turnidge, 
2004).  The prevalence of resistance in the commensal bacteria of humans and animals 
may reflect the selective pressure of antimicrobial usage and is a potential indicator of 
resistance in future infections (Anderson et al., 2003).  EC has served as an indicator of 
AMR for Gram-negative enteric bacteria and the emergence of strains showing multi-
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resistance is a public health concern (Guerra et al., 2003).  EC and EF are used 
internationally as indicator bacteria for AMR because of their high prevalence in animal 
feces, and because they harbor several resistance determinants (Witte, 2000; Catry et al., 
2003). 
EC is a member of the family Enterobacteriaceae.  Members of this family of 
bacteria are part of the normal intestinal flora of animals and humans.  EC is a Gram-
negative, oxidase-negative, non-spore forming, non-acid fast straight rod (0.3-1.0 x 1.0-
6.0µm).  EC is able to grow on simple nitrogen and carbon compounds and grows well 
in aerobic and anaerobic environments.  It has been shown to be prolific in the 
environment as a result of fecal contamination and can survive for weeks in optimal 
conditions in the environment (Brenner, 1984).  EC is typically found in the lower 
intestinal tract (ileum and large intestine) and is an important commensal of both animals 
and humans.  There has historically been disagreement among scientists over the ability 
of animal strains of EC to colonize humans (Phillips et al., 2004).  Recent research has 
indicated that transfer may be limited due to reduced ability of animal strains to colonize 
the human alimentary tract (reviewed by van den Bogaard et al., 2001).  Studies 
employing molecular methodologies have found strain differences in human and animal 
isolates even when the two species are in close contact (Kariuki et al., 1997; Kariuki et 
al., 1999; van den Bogaard et al., 2001).  The abundance of EC implicates them as likely 
candidates for the spread of resistance genes and vectors between the bacterial 
populations of animals and humans; however, their abundance also makes such spread 
difficult to trace (O’Brien, 2002).  Within the Gram-negative bacteria, a substantial 
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portion of the resistance genes present on plasmids and transposons are incorporated into 
Class 1 integrons (Winokur et al., 2001; Leverstein-van Hall et al., 2002).   
The Role of Enterococcus faecium in Resistance Transmission 
EF is a species of the genera Enterococcus, which are Gram-positive cocci 
(~1µm diameter).  EF are facultatively anaerobic, occur singly, in pairs, or short chains, 
and show no hemolysis on blood agar after 24 hours (may see alpha hemolysis after 48 
h).  EF is a normal inhabitant of the intestinal tract of animals and humans as well as the 
genital tract of humans.  EF has been show to be extremely hardy and can survive on 
environmental surfaces for several weeks at a time (Brenner, 1984). 
EF, specifically vancomycin resistant EF (VRE) are a major concern for public 
health and are a source of heated debate regarding transmission dynamics between 
animals and humans.  VRE first appeared in humans in the United States in 1998 
(Martinez et al., 2003).  There is no known reservoir of VRE in the United States other 
than colonized patients in the hospital setting and transmission represents horizontal 
spread from patient to patient usually in the hospital setting (Martinez et al., 2003).  In 
the United States, VRE are the third most prevalent source of nosocomial bacteremia, 
and nearly 25% of Enterococci isolated from nosocomial infections (hospital setting) are 
resistant to vancomycin (Houghton, 2002).  The vanB gene is the most prevalent 
resistance trait genotype found among Enterococci in the United States and induces 
varying levels of resistance to vancomycin (Low et al., 2001).   
In Europe, food-producing animals are the likely reservoir of one type of VRE; 
namely, EF strains with the vanA AMR gene (Salisbury et al., 2002).  It is believed that 
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is a result of the use of the growth promoter avoparcin in food animals in Europe 
(Salisbury et al., 2002).  VanA resistance is typically plasmid borne with genes carried 
within a conjugative transposon and confers high level resistance to vancomycin (Low et 
al., 2001).  The lack of a reservoir of VRE in the United States as compared to Europe 
has led to much speculation about the dynamics of VRE transmission between animals 
and humans.   
Phenotypic Expression of AMR 
More than 1021 diverse types of bacteria live and compete with each other on and 
in people, animals, and within the environment (O’Brien, 2002).  These organisms 
interact with their environment and respond to stress by modifying their physiological 
status.  When faced with a stressor, some organisms readily adapt while others die off.  
In the case of exposure to antimicrobials, those organisms which are able to survive may 
become resistant to antimicrobials and this resistance can then be propagated within the 
general bacterial population.  Further, resistance can be inherited and can persist for 
generations after the initial exposure (Heinemann, 1999).  Phenotypic susceptibility 
patterns of indicator bacteria such as EC and EF from healthy animals are suggested to 
be good predictors of resistance in the bacterial population at large (Catry et al., 2003).  
Minimum inhibitory concentration (MIC), or breakpoint susceptibility testing, is an in 
vitro diagnostic procedure for antimicrobial susceptibility testing of Gram-positive and 
Gram-negative bacteria, and has been a widely used method since its inception in the 
early 1980’s (Larkin et al., 2004).  By use of a 96-well plate dosed with selected 
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antimicrobials in a microbroth dilution series, investigators are able to assess the level at 
which a bacterium is able to resist treatment with a particular antimicrobial agent.  
Genetic Linkage of AMR  
Most AMR genetic traits occur in linked arrays rather than as a result of chance 
or mutation (Summers, 2002).  When exposed to an antimicrobial agent, a bacterium 
with genetically linked resistance mechanisms may possibly become resistant to multiple 
antimicrobials, even to ones unrelated to the agent given (Barza, 2002; Summers, 2002).  
As an example, antimicrobial co-selection appears to play a role in vancomycin 
resistance.  In Denmark, VRE resistant to macrolides and tetracyclines have been 
documented (Aarestrup, 2000).  After the ban of avoparcin, VRE was expected to 
decline dramatically, however, the decline was not realized until the use of tylosin was 
halted.  Glycopeptide resistance (GRE) remained around 20% in swine (Aarestrup, 
2000).  This finding suggests that co-selection may be the culprit as the resistance genes 
for both agents are located on the same conjugative plasmid (Aarestrup, 2000; Hasman 
and Aarestrup, 2002).  
Exposure to other chemicals, such as heavy metals, can also select for AMR 
bacteria.  Antimicrobial co-resistance has been recorded in the microbial population of 
ecosystems contaminated by metals in the absence of antimicrobial selection (Levin et 
al., 1997).   Furthermore, the mechanisms of genetic linkage such as plasmids, 
transposons, and integrons are likely ancient in terms of their evolution and appear to 
significantly pre-date the use of antimicrobials by humans; this, in turn, may aid the 
transmission of resistance characteristics within the population (Summers, 2002).  This 
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also may indicate the important role of co-selection and co-resistance in the ecology of 
AMR and transmission potential from animals to humans and vice-versa.  
Transmission of Resistant Bacteria from Animals to Humans 
In the era of modern medicine it is widely argued that use of antimicrobials in 
animal agriculture has led to increased antimicrobial resistance in humans.  While this 
argument has potential merit, there is a distinct lack of empirical evidence with which to 
characterize the basis for potential transmission between animals and humans.  Finding 
the “smoking gun” of antimicrobial resistance is important, but virtually impossible due 
to the widespread distribution of resistance genes, and because most drugs are used in 
multiple animal species as well as humans (Isaacson and Torrence, 2002). 
Many researchers appear to have adopted a model of transmission from animals 
to humans which neglects the fundamental ecology of humans interacting with animals 
in complex production systems (Barber et al., 2003).  Moreover, uni-directional models 
ignore other potential reservoir species as well as environmental interactions between 
potential hosts and the pathogen or commensal bacteria of interest (Halling-Sorenson et 
al., 1998; Meyer et al., 2000; Summers, 2002).  Few studies have addressed the risk of 
antimicrobial use and the potential maintenance of resistance in swine populations 
(Dunlop et al., 1998a).     
Further, evidence that antimicrobial resistant bacteria have been transmitted to 
humans is at best circumstantial, and based primarily on qualitative data from case 
reports (Khachatourians, 1998).  Resistant bacteria have been shown to reach the 
environment via sewage (Harwood et al., 2001) and it should not be ignored or 
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overlooked that both food animals and humans may have acquired resistance from either 
environmental contamination or a common source exposure.  Logically, humans 
contribute to the pool of resistant bacteria via human waste discharged into the 
environment (Harwood et al., 2001) and could possibly spread resistant bacteria directly 
to animals that come into contact with infected individuals (e.g., farm workers).  
Evidence exists that swine herds are 11 times more likely to have a high prevalence of 
Salmonella spp. when there is no toilet facility on the premises for human workers as 
opposed to when toilet facilities are provided (Funk et al., 2001). 
AMR studies to date have included a multitude of case-control and cross-
sectional designs.  More than 100 case-control studies relating to AMR have been 
conducted with numerous conflicting results regarding which risk factors are important 
for AMR (Patterson, 2002).  Some studies have indicated the importance of a particular 
risk factor, only to have subsequent studies find no significant relationship.  This 
variation may be due to differences in study design, case definition, and control 
selection.  A major limitation to the case-control approach for studying AMR is that the 
case-control study can only provide estimates of ratio measures of effect because it 
artificially inflates the disease/outcome prevalence in the source population.  This flaw 
in the case-control study design is that only a portion of the population of interest is 
sampled based on disease status rather than following subjects based on exposure, which 
allows for calculation of “time at risk” (Rothman, 2002).  
Numerous cross-sectional studies have focused on the prevalence characteristics 
of AMR in both humans and animals.  Recent cross-sectional studies have focused on 
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the prevalence of AMR bacteria in swine, cattle, poultry, goat and human isolates 
collected over various periods of time (Dunlop et al., 1998b; White et al., 2002; Guerra 
et al., 2003; Lanz et al., 2003; Zhao et al., 2003; Larkin et al., 2004).  All of these studies 
employed either phenotypic (e.g., MIC) or a combination of phenotypic and genotypic 
(PCR, PFGE) analyses to address the level of AMR in bacteria in their designated 
population of interest.  Overall, these studies indicated that the level of AMR in host 
bacteria varies both within and between species and that genetic mechanisms such as the 
integron appear to play a significant role in the potential for transmission of AMR gene 
cassettes both within and between species (animal to human).  
While these studies help to assess the level of AMR in many populations of 
interest and may serve as good proxies for longitudinal study designs (Rothman, 2002), 
they suffer from the inherent limitation of the cross-sectional study design.  Because 
cross-sectional studies measure both exposure and outcome at the same time, causality 
can not be assessed.  Indeed, in most of these studies direct exposure assessments of the 
humans to the animals or animal products were not even conducted.  So, while these 
findings may be suggestive of a relationship between antimicrobial resistant bacteria in 
food animals and humans, they certainly do not provide evidence of a causal 
relationship.  Moreover, all of these studies have explored AMR characteristics in an 
open population.  Given the flow of animals, humans, food products, and the potential 
interactions between humans and animals in these populations it would be virtually 
impossible to make a quantitative statement of the risk of antimicrobial usage to human 
health as a result of transmission from animals to humans. 
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Studies such as the Hayes et al. (2003) assessment of resistance levels in retail 
meats attempt to bridge the gap between the AMR found in animals and humans by 
addressing the risk posed by consumption of animal products by human consumers.  The 
authors purchased 981 packages of retail meat from 263 grocery stores during the study 
period to assess the prevalence of AMR bacteria, specifically Enterococcus species, in 
products destined for human consumption.  They did not obtain any samples from 
human consumers or potential consumers of the products and as a result were not able to 
directly assess exposure due to consumption of animal products.  This type of study also 
fails to address potential cross-contamination in the farrow-to-fork continuum such as 
transmission of resistance from human workers to food animals, contamination as a 
result of slaughter plant processing, retail packaging, transportation to retailers, and 
handling of the product in the retail setting.  Humans have been found to transmit 
zoonotic pathogens to animals with which they have contact (Barber et al., 2003).  
Moreover, studies that have focused on food-related outbreaks may not accurately 
represent the “day-to-day” transmission which would theoretically account for most 
AMR in humans as a result of consumption of food animal products (Barber et al., 
2003).  
In order to implicate the use of antimicrobials in animal agriculture as the source 
of AMR in humans, treatment failures in human disease must include a characterization 
and accounting of the continuity of the bacterial resistance gene ‘flow’ from animals, 
through slaughter, food processing interventions, retail distribution (if applicable), food 
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preparation, human consumption, disease outbreak, antimicrobial treatment, and 
ultimately failure in the patient (Shryock, 1999).   
Other studies have attempted to address the transmission dynamics of AMR by 
studying the resistance traits and characteristics in animal workers, their families, and 
their animals.  Kariuki et al. (1999) employed genotypic methods to characterize the 
resistance traits of EC found in children and chickens living in close contact.  While they 
found a high level of relatedness between the chicken isolates, there was no significant 
relationship between the patterns of resistance characteristics in children and chickens in 
linked households.   
van de Bogaard et al. (2001) took this framework a step farther by assessing the 
resistance in EC of poultry, poultry workers, and poultry slaughterers in the Netherlands.  
The authors tested fecal samples from poultry, farm workers and slaughter-plant workers 
and correlated these data with antimicrobial usage history for a period of three months 
prior to the study.  Using a combination of susceptibility testing and PFGE to determine 
the genetic relatedness of isolates, the authors found results that may be suggestive of 
spread of resistance from animals to humans.  While this study incorporates historical 
data on antimicrobial usage, it suffers from the previously mentioned limitation of cross-
sectional study designs (inability to address causality).  In addition, the authors allowed 
the farmers to collect the poultry fecal samples as well as their own fecal sample.  This 
could allow for contamination of one or both samples.  The authors also received a fecal 
sample from a farmer with no broilers on his farm at the time of the study.  This sample 
was noted, but the authors do not indicate if these results were used and this may 
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indicate a possible source of bias in the study.  Overall, 27 different AMR patterns were 
found with only 5 showing similar traits between poultry and poultry workers, and only 
3 of those were found in farmers and animals on the same farm (van de Bogaard et al., 
2001).  The authors do not indicate which farms these samples came from nor is there 
any analysis of farm factors that may play a role in these results (e.g., antimicrobial 
usage, housing and crowding of animals, animal handling practices).  Further, the ability 
to extrapolate these findings to other populations is limited due to potential inability to 
generalize the results to the general population.  
Although there is little doubt that cross-species (animal to human, human to 
animal) transmissions can occur, there are presently little or no quantitative longitudinal 
data available for reliable risk assessments (Isaacson and Torrence, 2001).  There is a 
need for controlled epidemiological studies utilizing stable, integrated animal and human 
populations over time.  Current research in AMR has largely been unable to achieve this 
goal due to lack of an integrated and closed study population, coupled with the difficulty 
of establishing a cause-and-effect relationship and assessing a true risk of transmission 
of AMR from animals to humans.  
One of the greatest limitations in the study of AMR and transmission risk from 
animals to humans has been application of a suitable risk assessment framework.  Both 
the Codex Alimentarius Commission (CAC) and the European Union Scientific 
Committee for Food have adopted a four-step risk assessment framework: hazard 
identification, exposure assessment, hazard characterization and risk characterization 
(Snary et al., 2004).  In the United States, the Environmental Protection Agency (EPA) 
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and the U.S. FDA Center for Veterinary Medicine (CVM) have similar risk assessment 
methodologies: hazard identification, dose-response, exposure assessment, and risk 
characterization.  
One of the problems with applying a risk assessment framework to AMR lies in 
the inability to move from qualitative to quantitative risk assessment.  In order to 
quantify “risk”, a researcher must be able to calculate a dose-response relationship.  This 
requires valid longitudinal data, which to date are lacking in the epidemiological 
literature.  In addition, the exposure assessment is likely to be difficult given the “open” 
status of the population.  People may have a multitude of pathways of exposure each 
varying to some extent based on the geographic area, activities of the person or 
population, food sources and eating habits, and genetic characteristics of the individual 
and population.  Characterization of the “risk” of transmission of AMR from animals to 
humans will continue to be difficult until the dose-response relationship and the 
exposure assessment/hazard characterization issues are addressed. 
In conclusion, AMR is a complex ecological problem that requires quantitative 
data on both the characteristics (phenotypic and genotypic) and transmission dynamics 
within the farm-to-fork continuum before any definitive statement of risk of transmission 
from animals to humans can be definitively made.  This research project and the 
continuing longitudinal project will for the first time attempt to address this need by 
working in a uniquely integrated population of humans and animals experiencing 
minimal outside influence via in- and out-migration and food sourcing.  
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MATERIALS AND METHODS 
Study Population 
During the study period, the study population was uniquely composed of groups 
of humans and swine in a semi-closed vertically integrated agri-food system.  The 
population of both humans and swine were located across multiple sites in the state of 
Texas, with 13 of these sites housing both species.  There was very limited movement of 
swine into the system and no movement of live animals or pork product out of the 
system.  Almost all herd replacements were reared within the system, with purebred 
boars and gilts comprising the only outside seedstock purchased.  Purchased boars were 
held in quarantine at a single, isolated swine unit.  Swine moved vertically within the 
system from farrowing units to nurseries and finally to grower-finisher barns until 
slaughter.  All swine raised on the farm units were slaughtered (at a single facility), 
processed, and consumed within the system (Figure 2).  
In addition, all processing and transportation equipment was owned by the 
operation. Each swine unit relied on an operation-owned feed processing facility and 
cooking facility for human food waste.  Properly cooked food waste was fed back into 
the swine operations at each site.  In fiscal year 2000, the packing plant facility 
processed and shipped approximately 9.5 million pounds of pork products.  These 
products fed a total human population of 180,000 individuals within the study system.  
The slaughter plant had 380 employees who worked 5 days per week (2 shifts/day) and 
the plant was inspected by the Texas Department of State Services.  Approximately 
50,000 hogs were slaughtered each year within the study system.  
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Figure 2. Unidirectional flow of swine within the study population. Dual housing 
(DH) indicates integrated units which house humans and swine. 
 
* DH-5 provides replacement stock for units DH-1 to DH-4.  
**Swine moved from any farrow-finish unit to any grower finisher unit. Eight of 13 swine production units in the 
system were sampled during the course of this study. 
 
Movement of humans and swine was quite restricted both coming into and 
leaving the system.  New residents to the system came through a central intake unit prior 
to being assigned to their permanent housing location.  Swine purchased outside of the 
study system also came through a centralized intake unit prior to being transferred to the 
farrow-finish or grower-finish swine operations.  Approximately 130,000 individuals 
were housed within the system and all meals were centrally prepared and consumed 
within each unit.  Approximately 95% of the population was male and the average age 
was 36 years.  A total of 62 human housing units comprised the study population with 
only 10 of the human housing units sampled for this study.   
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Criteria for unit inclusion into the study group included: presence of a swine 
operation, close proximity to Texas A&M University, and ease of access for sample 
collection.  The selected units represented: 1 intake unit for new residents who entered 
into the system, 8 of the 13 human housing units with swine operations represented 
cohorts of swine and non-swine workers, and the single unit with human cohorts for 
non-swine workers, and packing plant workers (Figure 3).  Human populations 
fluctuated, but approximately 1500 residents were housed at the human intake unit, 3000 
residents comprised the swine worker cohort, and 18,000 comprised the non-swine 
worker (control) cohort across all 10 units (anonymous personal communication).  
Approximately 350 employees worked at the packing plant facility during the study 
period.  The packing plant was composed of four main areas: kill floor, cooler, cut room, 
and sausage prep room.  Swine were processed on the kill floor, and then moved into 
storage in the cooler for a 24-hour period.  Upon removal from the cooler the carcasses 
were transferred to the cut room where fresh meat cuts (ham, loins, ribs, shoulders, pork 
roll, and party mix) were prepared and boxed.  Sausage was prepared in a separate room 
within the packing plant, which was the final processing step.  
Sample Collection 
Initial wastewater grab samples (n=420) were collected by trained facility staff at 
each of the designated human housing units on a biweekly basis for four months (May – 
Aug. 2003). A final set of samples (n=105) were collected in the spring of 2004 (Feb.—
Mar.).  Samples were obtained by suspending a collection bucket into the center of the 
flow channel, rinsing 3 times before raising, and subsequently transferring a 100 ml 
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aliquot into a sterile pre-labeled 100 ml container.  Each housing cohort was sampled at 
pre-designated manhole locations representing each housing cohort at 10:00, 12:00, and 
14:00.   
 
 
Figure 3.  Unidirectional flow of human residents in the study population. DH 
indicates integrated units which housed humans and swine. 
 
In addition, a wastewater plant influent sample was collected for each of the 10 sampled 
units by a privately licensed and contracted agency (Figure 4).  During each bi-weekly 
sampling period, a total of 7 samples were collected from each of the 9 resident units 
containing 2 housing cohorts (swine worker, non-swine).  Samples were stored on ice, 
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and within 48 hours of collection all samples were shipped to the USDA-ARS facility in 
College Station, TX for analysis.  
 
 
Figure 4. Human housing sample collection location by unit type.  
 
X indicates a sampled location. 
 
Initial swine fecal samples (n=61) were collected in the fall of 2002 (Sept. – 
Nov.).  In the summer of 2003 additional swine fecal samples (n= 95) were collected 
(May – Sept.) using the following sampling methodology.  Four composite swine fecal 
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farm (Figure 5).  Two composite fecal samples were collected from each of the 3 
grower-finisher units along with a combined floor-wash and a lagoon sample (Figure 5).   
A final set of swine fecal samples was collected in the spring of 2004 (n=305).  
Individual fecal samples were collected from the swine quarantine facility whenever 
outside boars were purchased.  No other outside purchases of swine were made during 
this study.  Swine samples were collected by veterinarians in charge of swine health at 
the operation and transported to USDA-ARS, College Station, Texas.  
 
 
Figure 5.  Swine sample collection by location. 
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Laboratory Analysis 
Upon arrival at the USDA facility, human wastewater samples were handled as 
follows: 32 ml of wastewater was transferred to a 50 ml conical tube that was labeled 
with the unit, sample location, date and time of collection.  Eight ml (20% v/v) of sterile 
glycerol was added to each tube.  Swine fecal samples arrived in labeled 50 ml conical 
tubes and were covered with glycerol prior to freezing.  Both wastewater and fecal 
samples were frozen at -72oC until processing, when the samples were removed and 
thawed in a 37oC water bath.  A loop of swine feces was collected from the thawed 
sample using a sterile inoculating loop and mixed with 1ml of sterile saline.  The thawed 
wastewater samples were mixed using a sterile inoculating loop, and both swine fecal 
and wastewater samples were streaked onto CHROMagar-E.coli™ (DRG International, 
Mountainside, NJ) agar, as well as onto Difco™ mEnterococcus agar (ME) (Becton 
Dickinson, Sparks, MD) that contained 20 µg/ml of vancomycin.  EC samples were 
incubated at 37oC for 24 hours, and EF at 45oC for 24-48 hours, upon which further 
microbial characterization for each species followed (Figure 6).  A single EC isolate 
from each plate was selected based on morphology (Figure 6) and streaked on blood 
agar.   
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When present, a single VRE isolate from each plate was selected based on 
morphology (Figure 6) and streaked onto blood agar.  All VRE isolates were verified 
using biochemical tests (API, bioMerieux, Hazelwood, MO) to ensure correct speciation 
prior to further testing.  Some EC isolates were verified using the API Strep 20 
biochemical test kit (API, bioMerieux, Hazelwood, MO) to ensure correct speciation 
prior to further testing. EC isolates were verified using the API 20 biochemical test kit 
(API, bioMerieux, Hazelwood, MO) only if the isolate produced unusual growth on 5% 
sheep blood agar (normal growth consisted of large, round, smooth colonies).  Unusual 
growth was normally (but not limited to) large mucous colonies or large colonies with 
heavily ruffled edges which were dry in appearance. Upon confirmation of the bacterial 
identification, VRE samples were ribotyped using the RiboPrinter® system (Qualicon 
Inc., Wilmington, DE).  EC isolates from swine and human samples were used to create 
a total genomic DNA template by the boiling lysis method for subsequent genotypic 
analysis.  Both EC and EF (VRE) were screened for phenotypic characteristics as 
described in detail in the following sections.  Pure culture isolates of both species were 
frozen in triplicate at -72oC in a bacterial repository at the USDA-ARS facility.  
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Figure 6. Schematic flowchart of laboratory methods employed for E. Coli and 
Enterococcus faecium (VRE) analysis.  
 
Difco™ mEnterococcus agar (ME) (Becton Dickinson, Sparks, MD).  CHROMagar-E.coli™ (DRG International, Mountainside, 
NJ).  API Strep 20 biochemical test kit (API, bioMerieux, Hazelwood, MO).  NARMS CMV7CNCD and GPN panels (Trek 
Diagnostics Inc., Cleveland, OH).   Sigma water (Sigma-Aldrich, St. Louis, MO).  QIAgen clean-up kit (Qiagen, Hilde, Germany)  
Streak to Difco™ ΜΕ agar* supplemented 
with  20µg/ml of vancomycin and incubate 
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Streak to CHROMagar- E. coli™* and 
incubate at 37oC for 24 hours. 
Plates with growth streaked onto ME 
Agar and screened by colony 
morphology.  
E. faecium grows pinpoint, pale pink 
colonies on vancomycin plates.  All 
positive plates confirmed with API Strep 
20 kit*.  
VRE antimicrobial resistance levels 
tested using GPN* panel on 
Sensititre™ 
VRE positive samples grown 24 hrs in 
TSB enrichment broth.  
Mixed with 1 ¼ ml of glycerol, split into 
triplicate and stored at -72oC. 
Pick 1 blue, smooth colony.  If uncertain about 
purity of colonies, re-streak onto chrome a 
second time 
E. coli antimicrobial resistance levels 
tested using NARMS CMV7CNCD* 
panel on Sensititre™ 
E. coli positive samples grown 24 hrs in TSB 
enrichment broth.  
Mixed with 1 ¼ ml of glycerol, split into triplicate 
and stored at -72oC. 
Total genomic DNA PCR template created using 
one colony.  Place into 500 µl Sigma water*, heat 
at 95oC for 10 min. and freeze at -20o C. 
PCR Master Mix: 1X 
10X Buffer                      5 
µl 
MgCl2                            4 µl
dNTP’s                           5 µl
Amplitaq                      0.2 
µl 
Integron 3’ CS             0.5 
PCR Thermal Cycle: 
95oC                          10 minutes 
95oC                          1 minute 
55oC                          1 minute 
72oC                          1 minute 
Go to step 2 and repeat for 30 
cycles 
72oC                         10 minutes 
4oC                             forever 
 
Amplicons for PCR positive isolates were isolated using a 
QIAgen PCR clean-up kit* and sequenced by Texas A&M Gene 
Sequencing Laboratory. 
All VRE isolates Ribotyped to 
identify similar strains. 
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Phenotypic Characterization of Resistance 
Antimicrobial susceptibility was determined for EC and EF by measuring the 
minimum inhibitory concentration (MIC) to 16 and 19 antibiotics respectively (Tables 1 
and 2).  The micro-broth dilution method in Sensititre™ (Trek Diagnostics Inc., 
Cleveland, OH) test panels were used.  Custom panels (CMV7CNCD), as designed by 
the National Antimicrobial Resistance Monitoring System (NARMS) were used for EC 
and the GPN panel (Trek Diagnostics Inc., Cleveland, OH) for EF (VRE).  We utilized 
the NCCLS breakpoints for determination of resistance (National Committee for Clinical 
Laboratory Standards, 1999).  Isolates were screened using both manual inspection and 
the Sensititre autoreader system (TREK Diagnostic Systems, Inc., Cleveland, OH).  
Isolates with intermediate MIC’s were not considered resistant for our study.  The 
dilution levels in the NARMS panels used in this study did not go as high as the 
recommended NCCLS breakpoint for classification as resistant for amikacin on the 
Gram-negative panel, and ampicillin, chloramphenicol, and quinupristin/dalfopristin on 
the Gram-positive panel.  Therefore, we were not able to dichotomize and interpret 
amikacin results for the Gram-negative isolates.  We were also not able to dichotomize 
and interpret ampicillin, chloramphenicol, and quinupristin/dalfopristin results for the 
Gram-positive isolates. 
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Table 1. Interpretation criteria of 16 antimicrobial agents tested against E. coli. 
Antimicrobial Range Breakpoint 
Amikacin** 0.5 – 4 ≥ 64 
Amoxicillin/Clavulanic Acid 1 – 32 ≥ 32 
Ampicillin 1 – 32 ≥ 32 
Ceftriaxone 1 – 64 ≥ 64 
Cephalothin 2 – 32 ≥ 32 
Chloramphenicol 2 – 32 ≥ 32 
Ciprofloxacin 0.015 – 4 ≥ 4 
Trimethoprim/Sulphamethoxazole 0.12 – 4 ≥ 4 
Cefoxitin 0.5 – 16 ≥ 32 
Gentamicin 0.25 – 16 ≥ 16 
Kanamycin 8 – 64 ≥ 64 
Nalidixic Acid 0.5 – 32 ≥ 32 
Ceftiofur* 0.12 – 8 ≥ 8 
Sulphamethoxazole 16 – 512 ≥ 512 
Tetracycline 4 – 32 ≥ 16 
Streptomycin* 32 – 64 ≥ 64 
*No NCCLS interpretive standards exist for this antimicrobial. NARMS recommended breakpoint used. 
** No interpretation was made for this antimicrobial due to the dilution level on the panel. 
 
Table 2. Interpretation criteria of 19 antimicrobial agents tested against E. faecium. 
Antimicrobial Range Breakpoint 
Ampicillin** 0.12 – 8 ≥ 16 
Chloramphenicol** 2 – 6 ≥ 32 
Ciprofloxacin 0.5-2 ≥ 2 
Clarithromycin 0.12 – 4 ≥ 4 
Clindamycin 0.25 – 2 ≥ 2 
Erythromycin 0.12 – 4 ≥ 4 
Gatifloxacin* 0.06 – 4 ≥ 4 
Gentamicin (2-16µg/ml) 2 – 16 ≥ 16 
Gentamicin (500µg/ml) 500 ≥ 500 
Moxifloxacin* 0.25 – 4 ≥ 4 
Levofloxacin 0.12 – 4 ≥ 4 
Oxacillin + 2% NaCl 0.25 – 2 ≥ 2 
Penicillin 0.03 – 8 ≥ 1 
Rifampin 0.5 – 2 ≥ 2 
Streptomycin 1000 ≥ 1000 
Trimethoprim/Sulphamethoxazole 0.5 – 4 ≥ 4 
Quinupristin/Dalfopristin*,** 0.12 – 4 ≥ 8 
Tetracycline 4 – 32 ≥ 32 
Vancomycin 0.5 – 16 ≥ 16 
*No NCCLS interpretive standards exist for this antimicrobial. 
** No interpretation was made for this antimicrobial due to the dilution level on the panel. 
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Quality control strains EC 25922, EC 35218, EF 29212, and Pseudomonas aeruginosa 
27853 obtained from the American Type Culture Collection (ATCC, Manassas, VA) 
were used for broth microdilution susceptibility testing for the EC isolates.  ATCC 
Enterococcus faecalis 35218 served as the quality control strain for broth microdilution 
susceptibility testing for the EF isolates. 
Ribotyping 
Ribotyping matches the ribosomal RNA pattern of a bacteria to an identification 
library in order to assess genetic relationships between isolates.  Patterns from each 
isolate are placed into common groups based on their similarity of band position and 
intensity (Hollis et al., 1999). Genetic relatedness of bacterial clones of VRE were 
determined using the RiboPrinter® Microbial Characterization System (Qualicon Inc., 
Wilmington, DE) using the standard EcoRI DNA prep kit.  Isolates were compared to 
the DuPont identification library (Dupont, Wilmington, DE).  
Characterization of Integrons 
Total genomic DNA templates of EC isolates were created by suspending 1 
colony of pure culture isolate in 500 µl of Sigma water (Sigma-Aldrich, St. Louis, MO), 
heating at 95oC for 10 minutes to lyse the bacteria, centrifuging for 2 minutes to remove 
cell debris, and storing at -20oC .  Polymerase Chain Reaction (PCR) (cycles described in 
Figure 6) was used to amplify the Class 1 integron and subsequently any AMR gene 
cassettes which may be inserted between the integron variable regions (5’conserved 
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sequence and the 3’conserved sequence) as previously described by Levesque et al. 
(1995) and summarized in Table 3.  
 
Table 3.  Oligonucleotide primers used for PCR amplification. 
Gene   Primer   Sequence   Product size
   
 
Class 1 Integron 5’CS     5’-GGCATCCAAGCAGCAAG-3’ Variable
   
   3’CS     5’-AAGCAGACTTGACCTGA-3’   
 
 
PCR products were subsequently electrophoresed on 1.0% agarose gels stained 
with ethidium bromide.  A 100 base pair (bp) DNA ladder (Sigma-Aldrich, St. Louis, 
MO) provided a molecular size standard for all reactions.  PCR products were purified 
using a QIAquick PCR clean-up kit (Qiagen, Hilde, Germany) and frozen at -20oC.  PCR 
products were submitted for DNA sequencing at the DNA Core Facility in the 
Department of Veterinary Pathobiology, Texas A&M University, College Station, TX.  
AMR genes were identified by sequence comparisons using the BLAST program 
available at the National Center for Biotechnology Information (Altschul et al, 1997).  
BLAST search results were screened for the presence of AMR gene cassettes based on 
95% of the expected fragment size (600 bp) and a match of 95% or greater of the 
sequence of the fragment and the corresponding gene cassette(s).  
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Statistical Analysis 
Antimicrobial Resistance in EC  
MIC results for each of 15 antimicrobials were dichotomized for statistical 
analysis. Isolates with intermediate MIC’s were categorized as sensitive.  Basic 
descriptive statistics describing resistance to each of the 15 antimicrobials were cross-
tabulated for each explanatory variable in SPSS 11.5 (SPSS Inc., Chicago, IL).  
Variables tested in the analyses included the following: proportion of EC with 
phenotypic resistance by: host species (human versus swine), unit, unit type, housing 
cohort by host species and time of day (human only).  
Because responses within each geographic unit were not independent of each 
other due to collection of repeated samples at each unit, generalized estimating equations 
(GEE) were used to adjust for the within-unit dependence (Hardin and Hilbe, 2003) 
when there were sufficient observations to allow for modeling.  Potential explanatory 
variables that were analyzed as categorical variables utilizing GEE in a GLM 
(generalized linear model) framework (McCullagh and Nelder, 1989) included: host 
species and time of day.  GEE analysis was conducted using SAS PROC GENMOD 
(SAS Institute, Cary, NC) by regressing each antibiotic (dependent variable) on the 
independent variable in a GLM procedure using a binomial distribution, a logit link 
function, and an independent correlation structure repeating on unit as the cluster.  
Antibiotics that lacked model convergence were excluded from the analysis.  The other 
potential explanatory variables: unit, unit type, and housing cohort by species were 
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analyzed using asymptotic likelihood tests in SPSS due to insufficient observations 
(resistance to each antimicrobial) across each category.  
 Unit was assessed as an 11-level categorical variable.  Category H-IH 
corresponded to the human intake unit, category S-IH corresponded to swine intake unit, 
categories DH- 1 to DH- 8 corresponded to the units which housed both humans & 
swine and category SP corresponded to the slaughter plant.  
Unit type was assessed as a 4-level categorical variable and was analyzed for 
only those antimicrobials found to have significant differences between humans and 
swine as modeled in the host species analysis.  Category H-IH corresponded to the single 
human intake unit. Category DH corresponded to the 8 units housing both human and 
swine cohorts.  Category SP corresponded to the workers at the slaughter plant where all 
swine are processed.  Category S-IH corresponded to the swine intake unit (swine only) 
where newly purchased boars and replacement gilts came into the system.  
Housing type was initially assessed as a categorical variable with 4 categories for 
human samples: swine worker corresponded to swine worker housing, non-swine worker 
corresponded to non-swine-worker housing, p-plant corresponded to packing plant 
influent wastewater samples and influent corresponded to mixed influent samples.  A 
second analysis excluded human influent wastewater samples because they constituted a 
mixture of all of the cohorts and to allow direct assessment of differences among 
humans with and without direct swine contact.  A third analysis looked specifically at 
differences in swine workers and non-swine workers only.  Swine housing cohort was 
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assessed as an 8-level categorical variable: boars, dry sows, intake boars, lactating sows, 
lagoon, nursery, pig influent (wash water), and piglet.  
Time of day was assessed as a categorical variable for human wastewater 
samples only. Category A corresponded to samples collected at 10:00, category B to 
samples taken at 12:00, and category C to samples taken at 14:00.  Samples for each 
time of day were collected repeatedly from the same sample location.  Influent samples 
were not collected at any given time of day and were excluded from this category.  
Pan-susceptibility in EC 
 Pan-susceptible outcomes (i.e., susceptible to all 15 antimicrobials) in EC were 
dichotomized and compared by host species utilizing GEE in a GLM framework in SAS.  
The other potential explanatory variables: unit, unit type, housing cohort by species and 
time of day (human only) were assessed using asymptotic likelihood methods in SPSS 
due to model instability in GEE.  
Multiple Resistance in EC 
Multiple resistance outcomes in EC (potential range 0-15; isolates with resistance 
to 7 or more antimicrobials were grouped into a single upper category) were compared 
by: host species, unit, unit type, housing cohort by species, and time of day (human only) 
in a GLM framework utilizing a multinomial distribution and a cumulative logit link 
function (McCullagh and Nelder, 1989; Hardin and Hilbe, 2003).  GEE utilizing the 
repeat statement (by unit) and an independent correlation structure was used to adjust for 
within unit dependence for all potential explanatory variables.   
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Phenotypic Resistance Patterns within EC 
To further assess the pattern(s) of resistance within the study population, the total 
number of possible and actual phenotypes was calculated by resistance category (0-10) 
for each observation (n=895) using SPSS.  A new variable was created and each 
observation was assigned to the corresponding phenotype.  Unique phenotypes were 
identified and contrasted by species and within each unit to assess differences which 
require further study. 
Genotypic Resistance in EC 
 Potential genotypic resistance, as assessed by both the presence of a gene cassette 
coding for resistance and a Class 1 integron, in EC, was compared by host species 
utilizing GEE in a GLM framework.  Unit, unit type, time of day, and housing cohort by 
species were compared by asymptotic likelihood methods in SPSS due to model 
instability in GEE.  Isolates which were positive for the presence of an integron (n=51) 
were further assessed for the presence of a gene cassette by host species using a χ2 test in 
Epi-Info 2000 (CDC, Atlanta, GA).  Isolates containing AMR gene cassettes (n=31) 
were then assessed for differences by host-species using a Fischer’s exact test in Epi-
Info 2000.  
Antimicrobial Resistance in EF (VRE) 
MIC results were dichotomized for statistical analysis.  Isolates with intermediate 
MIC’s were categorized as sensitive.  Basic descriptive statistics describing resistance to 
each of the 15 antimicrobials were cross-tabulated for each potential explanatory 
variable in SPSS.  VRE (human only) were assessed by: unit, unit type, housing cohort, 
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and time of day utilizing either a Fischer’s exact test or asymptotic likelihood method in 
SPSS.  Unique phenotypes were identified and contrasted within each unit to assess 
differences which require further study. 
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RESULTS 
 
A total of 957 (525 human and 432 swine) samples were collected from 
September 2002 to March 2004 over 14 collection cycles.  Due to lack of uniformity at 
the beginning of the study and as a result of developing sampling methodologies, not all 
units and sample cohorts were represented equally within the dataset.  Early problems 
included inconsistent sample collection dates (every week instead of bi-weekly) and 
inconsistent labeling of the sample vials.  These problems were quickly addressed and 
sampling remained consistent throughout the remainder of the study.  Not all of the 957 
samples received during the study period were positive for EC or EF (VRE) growth.  As 
a result, a total of 895 observations (isolates) were used for statistical analysis of EC.   A 
total of 17 observations were used for statistical analysis of EF (VRE). 
Descriptive Statistics for Multi-resistance in EC 
Multi-resistance was assessed as a categorical outcome variable with 7 categories 
due to insufficient results in the highest categories (8-10) and in order to avoid statistical 
model instability during analysis (Tables 4.1. and 4.2.). 
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Table 4.1. Initial categories for multi-resistance. 
Multi-Resistance           
Category 
 
Frequency 
 
Percent 
0 313 35.0 
1 257 28.7 
2 111 12.4 
3 77 8.6 
4 57 6.4 
5 40 4.5 
6 23 2.6 
7 3 .3 
8 6 .7 
9 6 .7 
10 2 .2 
Total 895 100.0 
 
 
 
Table 4.2.  Re-classified categories of multi-resistance. 
Multi-Resistance  
Category Frequency Percent 
0 316 35.3 
1 260 29.1 
2 109 12.2 
3 74 8.3 
4 56 6.3 
5 40 4.5 
6 23 2.5 
7 17 2.0 
Total  895 100.0 
 
Phenotypic Resistance of EC by Species 
 Significant differences in resistance were observed between humans and swine 
(see Table 5) with swine at a higher risk for resistance to kanamycin (OR=30.3), 
streptomycin (OR=3.70), sulphamethoxazole (OR=2.44) and tetracycline (OR=22.22).  
Only one human isolate and no swine isolates displayed resistance to ciprofloxacin.  
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Table 5. Phenotypic resistance in EC assessed by host species: swine (n=379), 
human (n=516). 
Antimicrobial 
 
Percentage of 
resistant EC: 
swine 
 
 
Percentage 
of resistant 
EC: human  
 
χ2 Value 
Odds 
Ratio 
(human 
as 
referent) 
Amoxicillin/Clavulanic Acid 2.4 1.7 0.19 1.37 
Ampicillin 22.7                        14.3 3.27 1.75 
Cefoxitin                                                   3.7 2.1 0.67 1.76 
Ceftiofur 2.1 1.0 0.62 2.20 
Ceftriaxone 2.9 0.0039 2.33 7.68 
Cephalothin 26.9 29.1 0.72 0.89 
Chloramphenicol 4.7 2.9 1.70 1.67 
Ciprofloxacin 0.0 0.0019 . . 
Gentamicin 3.4 0.006 1.75 6.25 
Kanamycin 19.3 0.008 6.44 30.3* 
Nalidixic Acid 2.4 5.0 3.44 0.46 
Streptomycin 32.2 11.4 6.81 3.70* 
Sulphamethoxazole 23.7 11.4 5.08 2.44* 
Tetracycline 81.5 16.5 10.30 22.22** 
Trimethoprim/Sulphamethoxazole 2.4 8.3 3.59 0.27 
. denotes model that did not converge due to lack of resistance 
*p<0.05 **p<0.001 based on GEE score statistic 
 
Phenotypic Resistance of EC by Unit within Species 
 Significant differences (p<0.05) in resistance were observed across unit for each 
host species.  Resistance in human wastewater samples varied across unit for cefoxitin, 
ceftiofur, tetracycline, and trimethoprim/sulphamethoxazole (Table 6).  Significant 
differences (p<0.05) in resistance were observed in swine across geographic unit for 
amoxicillin/clavulanic acid, ampicillin, cefoxitin, ceftiofur, ceftriaxone, gentamicin, 
kanamycin, streptomycin, sulphamethoxazole, tetracycline, and 
trimethoprim/sulphamethoxazole (Table 7).   
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Table 6.  Phenotypic resistance in EC isolates by unit in human wastewater samples 
(n=516). 
Facility* and sample size (n)  within facility 
Percentage of Resistant EC  
Antimicrobial 
H-IH 
(n=11) 
DH-1 
(n=57) 
DH-2 
(n=57) 
DH-3 
(n=57) 
DH-4 
(n=59) 
DH-5 
(n=53) 
DH-6 
(n=48) 
DH-7 
(n=44) 
DH-8 
(n=71) 
SP 
(n=59) 
S-IH 
(n=0) 
p-
value 
Amoxicillin / 
Clavulanic Acid 0.0 8.8 1.8 1.8 1.7 0.0 0.0 0.0 0.0 1.7 - 0.059 
Ampicillin 
9.1 21.1 14.0 17.5 10.2 11.3 10.4 13.6 19.7 10.2 - 0.632 
Cefoxitin 
0.0 8.8 5.3 1.8 1.7 0.0 0.0 0.0 0.0 1.7 - 0.028 
Ceftiofur 
0.0 7.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 - 0.042 
Ceftriaxone 
0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 - 0.449 
Cephalothin 
36.7 35.1 21.1 31.6 30.5 28.3 29.2 36.4 31.0 18.6 - 0.536 
Chloramphenicol 
0.0 8.8 0.0 0.0 3.4 0.0 2.1 4.5 4.2 3.4 - 0.066 
Ciprofloxacin 
9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 - 0.556 
Gentamicin 
9.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0  0.0 1.7 - 0.354 
Kanamycin 
0.0 0.0 0.0 0.0 0.0 1.9 2.1 4.5 0.0 0.0 - 0.280 
Nalidixic Acid 
18.2 8.8 10.5 1.8 3.4 1.9 2.1 2.3 4.2 6.8 - 0.185 
Streptomycin 
0.0 14.0 3.5 10.5 8.5 16.9 16.7 9.1 14.1 11.9 - 0.234 
Sulfamethoxazole 
9.1 16.9 5.3 8.7 6.8 9.4 6.3 15.9 19.7 11.9 - 0.163 
Tetracycline 
0.0 14.0 12.3 7.0 18.6 18.9 35.4 11.4 14.1 22.0 - 0.007 
Trimethoprim / 
Sulfamethoxazole 9.1 12.3 0.0 8.8 3.4 3.8 4.2 13.6 19.7 6.8 - 0.001 
* H-IH denotes the human intake unit. DH- 1 to DH- 8 denotes units housing both humans and swine. S-
IH denotes the swine intake unit. SP denotes the slaughter plant. 
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Table 7. Phenotypic resistance in EC isolates by unit in swine fecal samples 
(n=379). 
 Facility* and sample size (n) within facility 
Frequency of Resistant EC  (%) 
 
 
Antimicrobial 
H-IH 
(n=0) 
DH-1 
(n=47) 
DH-2 
(n=44) 
DH-3 
(n=28) 
DH-4 
(n=48) 
DH-5 
(n=50) 
DH-6 
(n=52) 
DH-7 
(n=24) 
DH-8 
(n=33) 
SP 
(n=0) 
S-IH 
(n=53) 
 
 
p-value 
Amoxicillin / 
Clavulanic Acid 
- 8.5 0.0 3.6 8.3 0.0 0.0 0.0 0.0 - 0.0 0.006 
Ampicillin - 27.7 15.9 14.3 35.4 6.0 21.2 12.9 24.2 - 37.6 0.001 
Cefoxitin - 12.8 0.0 7.1 8.3 4.0 0.0 0.0 0.0 - 0.0 0.001 
Ceftiofur - 6.4 0.0 0.0 8.3 0.0 0.0 0.0 3.0 - 0.0 0.016 
Ceftriaxone - 10.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 - 9.4 0.002 
Cephalothin - 29.8 15.9 32.1 39.6 24.0 25.0 16.7 24.2 - 30.2 0.314 
Chloramphenicol - 10.6 0.0 3.6 6.3 2.0 1.9 0.0 9.1 - 7.5 0.089 
Ciprofloxacin - 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 - 0.0 - 
Gentamicin - 0.0 4.5 0.0 0.0 0.0 15.4 0.0 0.0 - 5.7 <0.0001 
Kanamycin - 10.6 15.9 10.7 14.6 10.0 32.7 12.5 6.1 - 45.3 <0.0001 
Nalidixic Acid - 6.4 2.3 3.6 0.0 2.0 0.0 0.0 0.0 - 5.7 0.162 
Streptomycin - 36.2 43.2 28.6 47.9 22.0 32.7 12.5 12.1 - 37.7 0.003 
Sulfamethoxazole - 14.9 18.2 14.3 33.3 26.0 19.2 8.3 27.3 - 39.6 0.019 
Tetracycline - 85.1 75.0 78.6 93.8 64.0 84.6 79.2 69.7 - 96.2 <0.0001 
Trimethoprim / 
Sulfamethoxazole 
- 0.0 0.0 3.6 2.1 2.0 11.5 0.0 0.0 - 0.0 0.011 
* H-IH denotes the human intake unit. DH- 1 to DH- 8 denotes units housing both humans and swine. S-
IH denotes the swine intake unit. SP denotes the slaughter plant. 
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Phenotypic Resistance by Unit type 
 Differences in resistance by unit type were modeled for the four antimicrobials 
which exhibited overall risk differences between host species.  There were significant 
differences in resistance by unit type (Table 8) in swine for kanamycin, 
sulphamethoxazole, and tetracycline.  There were no significant differences (p>0.05) 
across unit type for humans.   
Phenotypic Resistance of EC by Housing Type 
 Modeling indicated there were no significant differences in resistance by human 
housing cohorts for any of the 15 antimicrobials when influent samples (mixed) were 
included in the analysis (Table 9).  There were significant differences in housing type 
when influent (to the wastewater plant) was excluded from the analysis (packing plant, 
swine worker, non-swine worker only) for resistance to cephalothin (p=0.033) only (data 
not shown in Table 9).  There were also significant differences in resistance to 
cephalothin when packing plant influent samples and influent samples were excluded 
from the analysis (p=0.02) with non-swine workers 1.89 times more likely to have 
resistance to cephalothin (OR=1.89) than swine workers (data not shown in Table 9).   
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Table 8.  EC phenotypic resistance by unit type to each of 4 antimicrobials that 
exhibited significant risk differences (p < 0.05) between humans (n=516) and swine 
(n-379). 
                                                                                                                Unit-type*     
                                                                                                                   Frequency of resistant EC  
Antimicrobial Resistant Host Species 
(Frequency of 
EC) 
H-IH  
 
DH  SP  S-IH       p-value 
Yes 
No 
Human (n=4) 
Human (n=512) 
0 
11 
4 
442 
0 
59 
- 
- 
0.557 Kanamycin 
Yes 
No 
Swine (n=73) 
Swine (n= 306) 
- 
- 
49 
277 
- 
- 
24 
29 
 <0.0001    
Yes 
No 
Human (n=59) 
Human (n=457) 
0 
11 
52 
394 
7 
52 
- 
- 
0.259          Streptomycin 
Yes 
No 
Swine (n=122) 
Swine (n=257) 
- 
- 
102 
224 
- 
- 
20 
33 
0.357 
Yes 
No 
Human (n=59) 
Human (n=457) 
1 
10 
51 
395 
7 
52 
- 
- 
0.964          Sulphamethoxazole 
Yes 
No 
Swine (n=90) 
Swine (n=289) 
- 
- 
69 
257 
- 
- 
21 
32 
0.005       
Yes 
No 
Human (n=85) 
Human (n=431) 
0 
11 
72 
374 
13 
46 
- 
- 
0.074 Tetracycline 
Yes 
No 
Swine (n=309) 
Swine (n=70) 
 
- 
- 
258 
68 
- 
- 
51 
2 
0.001       
* H-IH denotes the human intake unit. DH denotes units housing both humans and swine. S-IH denotes 
the swine intake unit. SP denotes the slaughter plant. 
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Table 9.  Phenotypic resistance among human EC wastewater isolates by housing 
type (n=491)*. 
Antimicrobial Influent 
(n=157) 
Non-swine 
worker ( n=98) 
Packing-plant  
(n=36 ) 
Swine-worker 
( n=200) 
p-value* 
Amoxicillin / 
Clavulanic Acid 
2.5 1.0 2.8 1.5 0.774 
Ampicillin 11.5 18.4 8.3 14.5 0.327 
Cefoxitin 2.5 4.1 2.8 1.0 0.377 
Ceftiofur 1.3 0.0 0.0 1.0 0.454 
Ceftriaxone 1.3 0.0 0.0 0.0 0.205 
Cephalothin 30.6 36.7 19.4 23.5 0.057 
Chloramphenicol 4.5 1.0 2.8 3.0 0.429 
Ciprofloxacin 0.0 1.0 0.0 0.0 0.357 
Gentamicin 0.6 1.0 2.8 0.0 0.244 
Kanamycin 1.9 1.0 0.0 0.0 0.133 
Nalidixic Acid 5.1 4.1 8.3 4.5 0.803 
Streptomycin 12.7 16.3 11.1 8.5 0.244 
Sulphamethoxazole 13.4 13.3 13.9 9.0 0.511 
Tetracycline 13.4 21.4 22.2 14.5 0.250 
Trimethoprim/Sulphamethoxazole 10.8 7.1 8.3 7.0 0.602 
*A total of 25 samples were not identified to a specific housing type. 
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There were significant differences across swine housing types (Table 10) for resistance 
to amoxicillin, ampicillin, cefoxitin, gentamicin, kanamycin, streptomycin, 
sulphamethoxazole, and tetracycline. 
Phenotypic Resistance by Time of Day 
 
 Modeling showed there were no significant differences (p>0.05) in resistance 
across time of day for human wastewater samples. 
Pan-susceptibility in EC 
 Overall, 84% of human EC isolates were pan-susceptible compared with only 
15% in swine (Figure 7).  There were significant differences in pan-susceptibility 
between host species with humans being 7.76 times more likely to exhibit pan-
susceptible EC isolates (OR=7.76, p=0.0014).  There were no significant differences 
(p>0.05) in pan-susceptibility among human EC for unit, unit type, housing type or time 
of day.  There were significant differences within swine EC by unit (p=0.004) and unit 
type (OR= 8.3, p=0.011) with the DH units more likely to have pan-susceptible isolates 
than the swine intake and holding unit.  There were significant differences within swine 
EC by swine production groups (p=0.001) with finisher pigs having the most pan-
susceptible isolates.  
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Table 10. Phenotypic resistance among swine composite fecal samples by housing 
type (n=364)*. 
Swine Housing Type 
 Frequency (%) 
 
 
 
 
Antimicrobial 
 
 
Boar 
(n=11) 
Dry 
Sow  
(n=20) 
Finisher 
(n=73) 
Grower 
(n=50) 
Intake 
Boar 
(n=43) 
Lactating 
Sow 
(n=28) 
Lagoon 
(n=18) 
Nursery  
(n=27) 
Influent 
(n=64) 
Piglet 
(n=30)    
 
 
 
p-
value* 
Amoxicillin / 
Clavulanic Acid 
0.0 5.0 0.0 0.0 0.0 3.6 0.0 7.4 1.6 13.3 0.020 
Ampicillin 36.4 15.0 15.1 24.0 46.5 21.4 11.1 18.5 23.4 26.7 0.032 
Cefoxitin 0.0 5.0 0.0 2.0 0.0 7.1 0.0 11.1 3.1 13.3 0.019 
Ceftiofur 0.0 5.0 0.0 2.0 0.0 3.6 0.0 7.4 0.0 10.0 0.052 
Ceftriaxone 0.0 0.0 0.0 2.0 11.6 7.1 0.0 3.7 1.6 3.3 0.069 
Cephalothin  36.4 20.0 27.4 20.0 32.6 35.7 16.7 25.9 25.0 36.7 0.685 
Chloramphenicol 0.0 0.0 2.7 6.0 9.3 3.6 0.0 7.4 4.7 6.7 0.542 
Ciprofloxacin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 - 
Gentamicin 0.0 5.0 0.0 0.0 7.0 0.0 0.0 18.5 1.6 10.0 0.002 
Kanamycin 0.0 15.0 11.0 10.0 53.5 14.3 16.7 25.9 15.6 33.3 <0.0001 
Nalidixic Acid 0.0 0.0 0.0 2.0 7.0 3.6 11.1 0.0 1.6 3.3 0.184 
Streptomycin 9.1 35.0 20.5 30.0 44.2 28.6 11.1 59.3 28.1 63.3 <0.0001 
Sulfamethoxazole 27.3 15.0 13.7 10.0 44.2 17.9 16.7 44.4 18.8 53.3 <0.0001 
Tetracycline 100.0 70.0 75.3 92.0 95.3 75.0 50.0 81.5 79.7 93.3 <0.0001 
Trimethoprim / 
Sulfamethoxazole 
0.0 0.0 0.0 2.0 0.0 3.6 5.6 11.1 3.1 3.3 0.171 
* A total of 15 samples were not identified to a specific housing type. 
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Multiple Resistance in EC 
In contrast, 65% of swine isolates were in multi-resistance category 3 (resistance 
to 3 or more antimicrobials) or higher compared with only 35% of human isolates.  
There were significant differences for multiple resistance between host species with 
swine being at 4.81 times greater odds (OR=4.81, p<0.0023) of belonging to a higher 
category of multiple resistance across all units, and housing cohorts (Figure 7).   
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Figure 7. Frequency of multi-resistance* in EC by species 
 
* Multi-resistance category represents the actual number of antimicrobials except category 7 which 
encompasses 7 through 10.  
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There were no significant (p>0.05) differences in multiple resistance outcomes 
for each host species by unit.  There were no significant (p>0.05) differences in multiple 
resistance outcomes for each host species across unit type.  There were no significant 
(p>0.05) differences in multiple resistance outcomes for each host species across 
housing cohort.  There were no significant (p>0.05) differences in multiple resistance 
outcomes for humans across time of day (Figure 8). 
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Figure 8. Frequency of multi-resistance* in EC by time of day. 
 
*  Multi-resistance category represents the actual number of antimicrobials except category 7 which 
encompasses 7 through 10.  
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Phenotypic Resistance Patterns in EC by Species 
 To aid in presentation of the phenotypic results Table 11 defines abbreviations 
for antimicrobials in subsequent tables.  A total of 116 distinct phenotypes were 
observed during the study period with 20 of these accounting for 81.5% of all isolates 
(n=895) in humans and swine (Table 12).  The most commonly observed phenotypes by 
host species, excluding pan-susceptibility, were resistance to cephalothin (16%) in 
human isolates and tetracycline in swine (27%).  The highest level of multi-resistance 
found was to 10 antimicrobials: amo + amp + cefox + ceftio + ceftri + cephal + chlor + 
strep + sulpha + tet (See Table 11), in two human wastewater influent samples.  Both 
were taken from the same dual-housing (DH) unit on the same date and displayed 
identical phenotypes.  Of the isolates with resistance to 9 antimicrobials, three distinct 
phenotypes were observed with the predominant phenotype: amo + amp + cefox + ceftio 
+ cephal + chlor + strep + sulpha + tet, found in four isolates; first in a human swine 
worker sample in Aug. 2003 and subsequently in Feb. 2004 in 3 swine isolates from the 
swine farm where the swine workers from the aforementioned DH unit work.   
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Table 11. Antimicrobial abbreviations used for phenotype. 
Antimicrobial Abbreviation 
Amikacin ami 
Amoxicillin/Clavulanic Acid amo 
Ampicillin amp 
Cefoxitin cefox 
Ceftiofur ceftio 
Ceftriaxone ceftri 
Cephalothin cephal 
Chloramphenicol chlor 
Ciprofloxacin cipro 
Clarithromycin clarith 
Clindamycin clinda 
Erythromycin erythro 
Gatifloxacin gatiflox 
Gentamicin gen 
Kanamycin kan 
Levofloxacin levo 
Moxifloxacin mox 
Nalidixic Acid nal 
Oxacillin + 2% NaCl oxacil 
Penicillin pen 
Quinupristin/Dalfopristin quin 
Rifampin rifam 
Streptomycin strep 
Sulphamethoxazole sulpha 
Tetracycline tet 
Trimethoprim/Sulphamethoxazole tri 
Vancomycin vanco 
 
Among isolates with resistance to 8 antimicrobials, 3 phenotypes were observed: 
amox + amp + cefox + ceftio + cephal + strep + sulpha + tet was the only one having 
more than one observation.  This phenotype was first observed in a piglet in Feb. 2004 
and subsequently isolated from the same unit in a piglet and nursery sample in Mar. 
2004.  The multi-resistance phenotypes for resistance to 8, 9, or 10 antimicrobials appear 
to be nested in that each higher level phenotype differs from the next lower one by the 
addition of only one antimicrobial. 
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Table 12. Predominant phenotypes of both human and swine EC isolates. 
 
 
The only EC resistant to ciprofloxacin during the study period was isolated from 
a Feb. 2004 human intake sample and it was resistant to a total of 7 antimicrobials: amp 
+ cephal + cipro + gen + nal + sul + tri collected.  In addition to being the only isolate 
resistant to ciprofloxacin during the study period, this isolate was also rare in that it 
exhibited resistance to gentamicin, nalidixic acid and trimethoprim/sulphamethoxazole.  
Only a very few isolates exhibited single resistance to these antimicrobials (gen <2%, 
nal <4%, and tri <6%).  No other isolates showed multi-resistance to this combination of 
antimicrobials (gen, nal and tri). 
Genotypic Resistance in EC 
 PCR was run on a total of 729 EC isolates (n=420 human, n=372 swine) to detect 
the presence of Class 1 integrons.  Initial swine samples received in the fall of 2002 
Phenotype Frequency Percent 
Pansusceptible 313 34.97 
Tet 128 14.30 
Cephal 90 10.06 
Cephal + Tet  33 3.69 
Strep +  Tet 21 2.35 
Strep + Sulpha + Tet 19 2.12 
Amp 18 2.01 
Amp + Cephal+ Strep + Tet 14 1.56 
Nal 12 1.34 
Sulpha + Tet 10 1.12 
Amox + Cephal  9 1.01 
Kan + Tet 9 1.01 
Amp + Strep + Tet 9 1.01 
Amp + Cephal + Tet 8 0.89 
Kan + Strep+ Sulpha + Tet 8 0.89 
Amp + Tet 7 0.78 
Amp + Cephal + Tri+ Sulpha+ Strep 7 0.78 
Gen +  Kan + Strep+ Tet 5 0.56 
Amp + Kan + Strep+ Sulpha + Tet 5 0.56 
Cephal + Nal 4 0.45 
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(n=61) were not tested using PCR, nor were human samples received in the spring of 
2004 (n=105).  Of the 420 human isolates tested, a total of 56 (13%) were positive on 
initial screening for any Class 1 integrons.  A total of 23/56 (41%) remained positive on 
confirmatory screening.  Nine of these 23 (39%) were positive for AMR gene cassettes.  
The other 14 had DNA inserted into the integron (range 525-1000 bp) but did not match 
any known resistance genes in the Genbank database. Seven of 9 samples (78%) were 
positive for the aadA gene which encodes resistance to spectinomycin and streptomycin.  
Variants of dfr encoding resistance to trimethoprim were present in 3 out of the 9 
samples (33%).  The ant-3 gene that also encodes resistance to spectinomycin and 
streptomycin was found in only 1 isolate.  Of the 372 swine isolates tested, a total of 51 
(14%) were positive on initial screening for any Class 1 integrons.  Of these 36/51 (71%) 
remained positive on confirmatory screening.  Five of these 36 (14%) were positive for 
AMR gene cassettes with all 5 containing the aadA gene which encodes resistance to 
spectinomycin and streptomycin.  The other 31 had DNA inserted into the integron 
(range 200-990bp) but did not match any known resistance genes in the Genbank 
database. 
Statistically, there were significant differences between host species with swine 
isolates having greater odds for the presence of integrons (OR=2.33, p=0.0487).  No 
significant differences were found (p>0.05) for facility location, facility type, human 
housing cohort or time of day.  There were significant differences (p=0.006) between 
swine production groups (boars, dry sows, finisher, grower, intake boars, lactating sows, 
lagoon, nursery piglets, influent and piglets) with the grower group having lower odds 
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for the presence of a Class 1 integron than the nursery group (nursery as referent, 
OR=0.22, p=0.04).  Among all isolates with an integron present, human isolates were at 
higher risk for the presence of an AMR gene cassette (OR=6.36, p=0.003).  Comparing 
the isolates bearing gene cassettes coding for specific resistance to antimicrobials, there 
were no significant differences between host species (p>0.05) though there were few 
data to compare.    
Phenotypic Resistance in VRE 
 A total of 17 (3%) human wastewater samples were positive for VRE during the 
study period.  There were significant differences in VRE recovery by unit (p=0.001) 
with samples (n=17) taken from four different geographic locations representing all 
isolates positive for VRE.  Three of these were sampled from influent (mixed) human 
housing (swine workers and non-swine workers) and 14 were sampled from swine 
worker housing locations.  Statistically, swine workers were at higher risk for VRE than 
the other housing cohorts (OR=6.8, p=0.001).  There were no significant differences in 
VRE recovery (p>0.05) by unit type or time of day.  No VRE were isolated from swine 
samples.  From the 17 isolates, a total of 12 unique AMR phenotypes were observed 
with only four phenotypes found in multiple isolates (Table 13).  Of the four phenotypes 
with more than one isolate, none were observed in the same geographic unit.  Of the 
three isolates observed from mixed housing, 2 were from the same DH unit and collected 
on the same date. The other isolate was collected from a DH unit on the same date that 
VRE were isolated in swine worker housing samples within that unit.  
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Table 13. Phenotypes of human VRE isolates (n=17). 
 
Phenotype Frequency 
Cipro+ Clarith + Clinda + Erythro + Gen + Gen500 + Levo + Oxacil + Pen + Rifam + Strep +Tet +Tri + Vanco  2 
Cipro+ Clarith + Clinda + Erythro + Gen + Levo + Oxacil + Pen + Rifam + Strep +Tet +Tri + Vanco 1 
 
Cipro + Clarith + Clinda + Erythro + Gatiflox + Gen + Gen500 + Levo  + Oxacil + Pen + Rifam + Strep +Tet 
+Tri + Vanco 1 
 
Cipro+ Clarith + Clinda + Erythro + Gen + Gen500 + Levo + Oxacil + Pen + Rifam + Strep +Tri + Vanco  3 
 
Cipro+ Clarith + Clinda + Erythro + Gen + Gen500 + Levo + Oxacil + Pen + Rifam + Strep +Tet +Tri + Vanco 2 
Erythro + Gen500 + Pen + Rifam + Strep + Tet + Vanco 2 
 
Cipro+ Clarith + Clinda + Erythro + Gen + Levo + Oxacil + Pen + Rifam + Strep +Tet +Tri + Vanco 1 
Erythro +  Gen500 + Pen + Strep +Tet + Vanco 1 
Cipro+ Clarith + Clinda + Erythro + Levo + Oxacil + Pen + Rifam + Strep +Tet +Tri + Vanco 1 
 
Cipro+ Clarith + Clinda + Erythro + Gen + Gen500 + Levo + Oxacil + Pen + Rifam + Strep +Tri + Vanco 1 
 
Cipro+ Clarith + Clinda + Erythro + Gen + Gen500 + Levo + Oxacil + Pen + Rifam + Tet +Tri + Vanco 1 
 
Cipro+ Clarith + Clinda + Erythro + Gen + Gen500 + Levo + Oxacil + Rifam + Tet +Tri + Vanco 
 
1 
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DISCUSSION AND CONCLUSION 
 
In the present study, conducted from September 2002-March 2004, there were 
significant (p<0.05) differences in EC AMR between host species isolates (humans and 
swine) within the integrated study population.  Swine isolates were at higher risk for 
single and multiple resistance than human isolates.  In addition, pan-susceptibility was 
much more common in human EC isolates than in swine.  These findings are consistent 
with other studies which found AMR prevalence differences between humans and 
animals (Dunlop et al., 1998b; White et al., 2002; Guerra et al., 2003; Lanz et al., 2003; 
Zhao et al., 2003; and Larkin et al., 2004.  Dunlop et al. (1998b) studied resistance 
prevalence among fecal EC of swine taken from 34 farrow-finish farms in Canada.  
Observed resistance was predominantly to ampicillin, spectinomycin, and tetracycline 
with resistance varying more between farms than within.  The present study 
demonstrated similar results with resistance to each of the aforementioned antimicrobials 
varying across geographic location (unit).  The results of the Dunlop et al. (1998b) study 
also indicated that samples collected within a farm were more likely to be similar than 
those from different farms.  This underscores the need to adjust for the effects of 
clustering in similar study designs such as the present study.  White et al. (2002) looked 
at clinical Escherichia coli 0:111 isolates collected over a 24 year period to evaluate the 
prevalence of resistance in humans, swine, cattle, and poultry.  Their results indicated 
that swine isolates showed higher resistance to one or more antimicrobials than human 
isolates, but lower prevalence of Class 1 integrons.  The present study also found that 
swine isolates showed higher resistance to one or more antimicrobials, but found that 
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swine had a higher prevalence of Class 1 integrons while swine were more likely to have 
a AMR gene cassette present.  Guerra et al. (2003) looked at resistance prevalence in 
cattle, poultry and swine isolates collected directly from live animals (health status of the 
animal was not indicated).  Those authors found swine and poultry to have higher overall 
resistance prevalence than cattle.  Additionally, swine were found to exhibit significant 
resistance (31%) to spectinomycin.  While the present study did not assay spectinomycin 
it did look at streptomycin and gentamicin (also in the aminoglycoside drug class).  We 
found swine to have higher levels of resistance to streptomycin than humans and the 
only AMR gene cassettes found within swine were encoding resistance to both 
spectinomycin and streptomycin.  A study by Lanz et al. (2003) conducted in 
Switzerland addressed the resistance levels in dairy cattle, dogs, cats and swine.  The 
authors found higher levels of resistance in swine for streptomycin, spectinomycin, and 
gentamicin than the other animal species.  These findings are also similar to the present 
study which found high resistance in swine isolates to streptomycin.  While the present 
study did not indicate significant differences between humans and swine for gentamicin 
resistance, there were significant differences among swine housing types.  Zhao et al. 
(2003) studied the prevalence of Salmonella enterica serotype Newport in isolates from 
human, dairy cattle, poultry and swine. Interestingly, the authors found a high 
prevalence of Class 1 integrons (68%), but did not indicate how many were found from 
isolates of each species.  This is in contrast to the present study which did not find a high 
prevalence of Class 1 integrons or AMR gene cassettes in humans or swine.  Larkin et 
al. (2004) also looked at resistance in Salmonella isolated from hogs, cattle and poultry.  
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Higher levels of resistance were again found to streptomycin and tetracycline in swine. 
Additionally, swine isolates showed higher levels of multi-resistance than isolates from 
the other species.  Those findings are similar to the present study which found high 
levels of resistance to both streptomycin and tetracycline within swine isolates and a 
significantly higher risk of multi-resistance in swine isolates versus humans. 
Within host species of the present study, there were significant (p<0.05) 
differences in resistance of EC by geographic location (unit) for both human and swine 
isolates.  Documentation of antimicrobial usage was variable across geographic location 
as indicated by antimicrobial feed records for swine (generally tylosin and 
chlortetracycline used in feed rations) and based on the differences in hospital and clinic 
types across locations (data not shown) so these results may or may not be indicative of 
the role of antimicrobial usage in AMR.  After an extensive search of the literature, it 
appears that there is little information available about differences in resistance across 
multiple locations within an integrated population.  van den Bogaard et al. (2001) 
compared AMR in the Netherlands across chickens, poultry workers, and slaughter 
house workers and found similar resistance patterns in the three groups.  This was the 
most similar study in design and objective to the present study.  Employing a cross-
sectional study design the authors attempted to address the transmission risk from 
animal-to-human contact.  This is similar to the present study in the desire to address the 
potential transmission risk from animals to human or vice versa.  However, it differed 
significantly in approach.   The present study worked within a semi-closed integrated 
population consisting of swine, swine workers, and non-contact swine consumers, 
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whereas, the van den Bogaard study worked in an open population.  The study did find 
differential prevalence of resistance within the poultry population (broilers, and laying 
hens) which is similar to the present study’s finding of differential prevalence across 
swine housing types.   
When comparing human housing cohort (swine workers versus non-swine 
workers), there were no significant (p>0.05) differences in resistance of EC (except to 
cephalothin), multi-resistance, presence of a Class 1 integron, or VRE.  The lack of 
similarity in resistance between swine and humans (swine workers and consumers) 
supports the findings of Kariuki et al. (1999) who found no significant similarity in 
resistance and PFGE patterns in isolates from chickens and humans living in close 
contact.  This finding is in contrast to van den Bogaard et al. (2001) who found 
similarities in resistance patterns between humans and poultry with which they have 
close contact especially given that the present study found non-swine workers at higher 
risk for cephalothin resistance (OR=1.89).  However, van den Bogaard et al. do not 
indicate which farms these samples came from nor is there any analysis of farm factors 
that may play a role in these results (e.g., antimicrobial usage, housing and crowding of 
animals, animal handling practices).   
Swine isolates varied by housing for resistance to 8 of the antimicrobials with 
intake boars (received twice during the study), nursery piglets, weaned piglets, and 
lactating sows generally having more observed resistance than the other housing types.  
Piglets and lactating sows have been show to receive higher levels of antimicrobial 
treatment than other production groups (Akinna and Johnson, 1999).  Because data on 
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individual treatment of the animals with antimicrobials were not available, we were not 
able to assess the role of individual level factors in the observed AMR in the swine 
housing types. However, the high level of resistance observed in the intake boars 
suggests that the resistance may have been introduced as swine moved into the study 
population.  A study by Dunlop et al. (1998c) found that individual level treatments 
showed more variability than did group treatments for swine that were similar in age to 
the ones in our study.  However, swine samples collected for the present study were 
composite in nature and were collected across multiple pens, which suggests that some 
group-level factor (e.g., antimicrobials in the feed) could be playing a role rather than 
individual level factors.  Nonetheless, the aggregate nature of the data made this 
impossible to assess.  
Multi-resistance to up to 10 antimicrobials was observed in the human isolates 
and resistance up to 9 antimicrobials was observed in swine isolates.  Additionally, 
several unique phenotypes were found with both swine and human isolates in the present 
study.  Only one isolate resistant to ciprofloxacin was found and was sampled from the 
human intake and holding unit.  This indicates the possibility for the introduction of 
unique phenotypes into the system from incoming human residents.  A swine worker EC 
isolate with resistance to 9 antimicrobials was first identified in 2003 and later found in 2 
swine isolates from the same unit.  These findings point to the possibility of resistance 
traits being passed from humans to swine within the study population.  Similarly, the 
work of Barber et al. (2003) showed transmission of zoonotic pathogens from humans to 
animals with which they had contact, and that of Funk et al. (2001) which found higher 
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prevalence of Salmonella in swine when human toilet facilities were lacking.  However, 
our data are not comprehensive since we selected only one colony per plate.  As a result, 
temporal relationships could not be established.  In our study, a swine isolate with 
resistance to 9 antimicrobials was initially discovered and was subsequently found in 
two other swine in the same herd.  This would support the theory of horizontal 
transmission of resistance characteristics within swine housed in close proximity to each 
other.  
Human EC isolates were more likely to have an integron encoded AMR gene 
cassette than swine isolates, even though swine isolates were more likely to have a Class 
1 integron than human isolates.  Overall, a low prevalence of Class 1 integrons and 
AMR gene cassettes were observed in both human and swine isolates in this study, 
which is in contrast to recent studies by Winokur et al. (2001) and Leverstein-van Hall et 
al. (2002), in which a substantial portion of AMR genes in Gram-negative bacteria were 
located within the Class 1 integron.   
VRE were isolated only in human wastewater samples, and these findings are 
unique in that these represent to the author’s knowledge the first environmentally 
isolated human VRE in the United States.  VRE has been isolated from both dog feed 
and chicken feed in the U.S. in 1996 and 1999 respectively. Typically, vancomycin is 
administered to patients within a hospital setting; for example, persons on dialysis, in the 
intensive care unit (ICU), or immuno-compromised patients all may be candidates for 
treatment.  Virtually all VRE in the United States to date have been directly attributed to 
hospital cases and have been isolated in clinical samples or isolated from hospital 
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sewers.  The VRE in our study were predominantly isolated from swine worker samples.  
To find vancomycin resistance in healthy humans outside the hospital setting may 
indicate an important role of human carriers of VRE in its transmission.  The only other 
VRE (n=3) were found in mixed influent samples which would have been taken 
‘downstream’ from the housing cohorts and represented a combination of swine worker 
and non-swine worker wastewater.  The survival of VRE as they move downstream and 
encounter an environment rich with other organisms may indicate that they are able to 
compete with other micro-organisms and survive.  Given this capability, it is also 
possible that they may be able to move into the environment in the event of leaks in the 
sewage system.  While the available evidence in Europe suggests that VRE are 
transmitted from animals to humans (Harwood et al., 2001) and is attributed largely to 
the use of growth promoters such as avoparcin and virginiamycin in food animals 
(Phillips et al., 2004), we found no evidence of VRE in the animal population in our 
study which may suggest that humans are the primary reservoir for VRE in the United 
States.  While the general consensus is that VRE in humans in Europe is a result of 
animal to human transmission, there are several studies with findings to the contrary.  
Experimental studies appear to support some level of host-specificity in EF and an 
ingestion study conducted with human volunteers found no colonization as a result of 
consumption of animal strains of VRE (Phillips et al., 2004).  Due to the cross-sectional 
nature of our study, further studies will need to be conducted before any definitive 
statement can be made about the causality of our present findings. 
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Use of GEE (generalized estimating equations) for the statistical analysis of the 
aforementioned risk factors provided a good estimate of the population parameters under 
study while adjusting for potential dependence of response variables by unit.  GEE 
specifies only the marginal distribution of the outcome variable which produces 
estimates of the population parameters rather than cluster-specific values (Edwards, 
2000).  GEE methods can be used for both discrete and continuous outcome variables, 
but is most often used for correlated binary data.  GEE methods assume an s x 1 vector 
for the correlation matrix.  The estimate of the s x 1 vector is inserted into the equation 
and estimation proceeds to achieve a working correlation matrix.  The working 
correlation matrix does not always approximate the true correlation matrix, but good 
estimates of the population parameters are still achieved due to the robust nature of GEE 
methods (Edwards, 2000). 
To the author’s knowledge this is the first study to have looked at resistance 
within an integrated population of humans and swine.  The unique characteristics of the 
study population: 1) limited in and out migration of humans and swine; 2) raising, 
processing and consumption of swine products “in house”; and 3) the arrangement of 
cohorts of swine workers, slaughter plant workers, and non-swine contact consumers 
allowed for the first assessment of AMR within a “controlled” and semi-closed study 
population. Using a combination of phenotypic and genotypic methods, this study relied 
on an integrated approach to examining potential risk factors for AMR which should 
eventually lead to the type of data desperately needed to use in risk assessment modeling 
of AMR.  Moreover, this study is distinctive in that we used non-clinical, 
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environmentally isolated EC and EF rather than human clinical isolates or retail meat 
samples.  This reflects a more realistic approach of the “day to day” transmission 
potential and risk from animals to humans or vice versa.  While these findings are 
suggestive and thought-provoking, they can not be judged in any way to suggest 
causality at this time.  As an initial cross-sectional analysis, these findings will need to 
be followed and verified during an ongoing longitudinal study before causality can be 
addressed.  
Study Limitations 
Working within a semi-closed population represented a unique opportunity to 
study AMR within an integrated population of humans and swine.  Therefore, it will also 
have resulted in a decreased ability to generalize these results to the human and swine 
populations at large due to differences in population characteristics and the sampling 
strategy of the study.  Population groups chosen for inclusion into the study were 
selected as a convenience sample based on their proximity to our lab facilities and the 
ability to establish a working relationship with that particular administrative unit.  
Therefore, generalization of the findings beyond these particular groups should be 
cautioned.  Data on antimicrobial usage within both the human and swine population 
were not evaluated during this study.  Therefore the role of antimicrobial usage in the 
observed phenotypic and genotypic resistance could not be judged.   
The selection of only one colony of EC per plate may have resulted in a bias in 
the estimation of prevalence if multiple phenotypes and/or genotypes were present and 
not considered due to the aforementioned selection methodology.  Recognizing that 
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there will have been other AMR genotypes and phenotypes present on the media, but for 
financial reasons, we chose to analyze fewer isolates across a higher number of samples.  
Berge et al. (2003) studied EC resistance in dairy calves and sampled 5 colonies per 
plate.   Those authors’ noted a mean of 1.8 distinct AMR phenotypes per plate in their 
study, which considered upwards of five thousand isolates. This finding supports the 
selection of fewer isolates per sample.  Any potential bias associated with this selection 
methodology would be non-differential unless the isolate selection process was 
knowingly associated with the risk factors under study.  There could also have been bias 
if AMR phenotype was associated with a fitness disadvantage on the selective in vitro 
media used in this study.  These potential biases are common to all in vitro cultivation 
studies, not just ours. 
Due to the aggregate nature of the sampling procedure, it is possible that this 
study may suffer from aggregate bias, also known as the ecological fallacy.  In the 
ecological fallacy, associations observed at the group or aggregate-level do not 
necessarily reflect an association at the individual level.  In many cases, studies done at 
the population level are considered imperfect surrogates for individual level data, or 
initial studies which can suggest avenues of research to be conducted at the individual 
level.  While this may be true, and widely applicable to studies concerned with disease 
etiology, there are situations in which population level studies are the more appropriate 
approach.  If the variability within the population of interest is low but between-
population variability is high, then important associations may be missed by individual 
level study designs.  Dunlop et al. (1998b) studied the prevalence of AMR across 34 
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farrow-finish swine operations in Canada, and found that there was higher variability in 
resistance between farms than within.  These findings underscore the applicability of the 
aggregate approach to studies of AMR within populations.  The second situation in 
which a population level study may be more appropriate is if the level of prevention or 
intervention would be directed at the population level even if the preferred level of 
inference is to the individual.  AMR reduction and risk analysis strategies would likely 
be focused on both group-level and individual-level risk factors.  
The detection limit of the PCR assay (sensitivity) was not determined during the 
course of the study and subsequently our ability to consider an isolate truly negative was 
unknown.  As such, we may have misclassified isolates that were below the detectable 
limit as negative when they were indeed positive.  Also, integrons may be quite large in 
size, and may have been missed under the PCR parameters used in this study. Further, 
we did not assess the role of inhibitory compounds in the ability of the DNA to be 
amplified.  This may have been a significant issue given that the samples were 
environmental in nature.  One problem that presented itself late in this study was poor 
gene sequencing results in the last set of swine DNA samples (n=2) due to large amounts 
of primer dimer in the reaction.  
Recommendations for Future Studies 
 The ability to quantitatively measure AMR is a key component to addressing the 
risk of transmission from animals to humans or vise-versa.  In order to achieve that goal, 
future studies should look at community DNA samples for specific genotypic resistance 
characteristics over a longer period of time.  That coupled with the use of real-time PCR, 
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would allow for better quantification of the samples under study.  In addition, collection 
of individual level samples from within the human cohorts will allow for more accurate 
assessment of the resistance characteristics within the population and how they transfer 
over time.  Further assessment of antimicrobial usage both within the swine and human 
populations will be necessary to address the role of drug usage in AMR characteristics 
and transmission dynamics.  Tracking of new human residents and swine as they move 
into and through the system could aid in identifying unique AMR characteristics which 
are being introduced to the population from the outside.  This would allow for 
characterization of movement or lack of movement through the study system.  
Summary/Conclusions 
 To the author’s knowledge this is the first study to address AMR characteristics 
within an integrated population of humans and swine across multiple sites in the farrow-
to-fork continuum. Our study agrees with previously published work, further suggesting 
that: 1) the level of AMR to one or multiple antimicrobials is higher in swine than 
humans and 2) there are differences in resistance based on unit location, unit-type, and 
housing cohort within both humans and swine.  Unlike other studies, our study found no 
significant differences in resistance between swine workers and non-swine workers with 
the sole exception of resistance to cephalothin.  Further studies are necessary to 
quantitatively measure AMR and address the risk of transmission from animals to 
humans and vice-versa. 
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